Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1986 Mar;65:363–441. doi: 10.1289/ehp.8665363

Metabolism and possible health effects of aluminum.

P O Ganrot
PMCID: PMC1474689  PMID: 2940082

Abstract

Literature regarding the biochemistry of aluminum and eight similar ions is reviewed. Close and hitherto unknown similarities were found. A hypothetical model is presented for the metabolism, based on documented direct observations of Al3+ and analogies from other ions. Main characteristics are low intestinal absorption, rapid urinary excretion, and slow tissue uptake, mostly in skeleton and reticuloendothelial cells. Intracellular Al3+ is probably first confined in the lysosomes but then slowly accumulates in the cell nucleus and chromatin. Large, long-lived cells, e.g., neurons, may be the most liable to this accumulation. In heterochromatin, Al3+ levels can be found comparable to those used in leather tannage. It is proposed that an accumulation may take place at a subcellular level without any significant increase in the corresponding tissue concentration. The possible effects of this accumulation are discussed. As Al3+ is neurotoxic, the brain metabolism is most interesting. The normal and the lethally toxic brain levels of Al3+ are well documented and differ only by a factor of 3-10. The normal brain uptake of Al3+ is estimated from data on intestinal uptake of Al3+ and brain uptake of radionuclides of similar ions administered intravenously. The uptake is very slow, 1 mg in 36 years, and is consistent with an assumption that Al3+ taken up by the brain cannot be eliminated and is therefore accumulated. The possibility that Al3+ may cause or contribute to some specific diseases, most of them related to aging, is discussed with the proposed metabolic picture in mind.

Full text

PDF
363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALDRIDGE W. N., BARNES J. M., DENZ F. A. Experimental beryllium poisoning. Br J Exp Pathol. 1949 Oct;30(5):375–389. [PMC free article] [PubMed] [Google Scholar]
  2. ASK-UPMARK E. Precipitating factors in the pathogenesis of amyotrophic lateral sclerosis. Acta Med Scand. 1961 Dec;170:717–723. doi: 10.1111/j.0954-6820.1961.tb00290.x. [DOI] [PubMed] [Google Scholar]
  3. Aaronson R. P., Woo E. Organization in the cell nucleus: divalent cations modulate the distribution of condensed and diffuse chromatin. J Cell Biol. 1981 Jul;90(1):181–186. doi: 10.1083/jcb.90.1.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aisen P., Aasa R., Redfield A. G. The chromium, manganese, and cobalt complexes of transferrin. J Biol Chem. 1969 Sep 10;244(17):4628–4633. [PubMed] [Google Scholar]
  5. Aitio A., Järvisalo J., Kiilunen M., Tossavainen A., Vaittinen P. Urinary excretion of chromium as an indicator of exposure to trivalent chromium sulphate in leather tanning. Int Arch Occup Environ Health. 1984;54(3):241–249. doi: 10.1007/BF00379053. [DOI] [PubMed] [Google Scholar]
  6. Alder J. F., Samuel A. J., West T. S. The single element determination of trace metals in hair by carbon-furnace atomic absorption spectrometry. Anal Chim Acta. 1976 Dec;87(2):313–321. doi: 10.1016/S0003-2670(01)82260-1. [DOI] [PubMed] [Google Scholar]
  7. Alderman F. R., Gitelman H. J. Improved electrothermal determination of aluminum in serum by atomic absorption spectroscopy. Clin Chem. 1980 Feb;26(2):258–260. [PubMed] [Google Scholar]
  8. Alekseeva O. G., Vasil'eva E. V., Orlova A. A. Abolition of natural tolerance and the influence of the chemical allergen beryllium on autoimmune processes. Bull World Health Organ. 1974;51(1):51–58. [PMC free article] [PubMed] [Google Scholar]
  9. Alfrey A. C. Aluminum intoxication. N Engl J Med. 1984 Apr 26;310(17):1113–1115. doi: 10.1056/NEJM198404263101709. [DOI] [PubMed] [Google Scholar]
  10. Alfrey A. C. Aluminum intoxication. N Engl J Med. 1984 Apr 26;310(17):1113–1115. doi: 10.1056/NEJM198404263101709. [DOI] [PubMed] [Google Scholar]
  11. Alfrey A. C. Aluminum. Adv Clin Chem. 1983;23:69–91. doi: 10.1016/s0065-2423(08)60398-4. [DOI] [PubMed] [Google Scholar]
  12. Alfrey A. C., Hegg A., Craswell P. Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr. 1980 Jul;33(7):1509–1516. doi: 10.1093/ajcn/33.7.1509. [DOI] [PubMed] [Google Scholar]
  13. Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
  14. Alfrey A. C., Mishell J. M., Burks J., Contiguglia S. R., Rudolph H., Lewin E., Holmes J. H. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1972;18(0):257-61, 266-7. doi: 10.1097/00002480-197201000-00064. [DOI] [PubMed] [Google Scholar]
  15. Allison A. C. Mode of action of immunological adjuvants. J Reticuloendothel Soc. 1979 Dec;26(Suppl):619–630. [PubMed] [Google Scholar]
  16. Alzheimer's disease, Down's syndrome, and aging. Ann N Y Acad Sci. 1982;396:1–199. [PubMed] [Google Scholar]
  17. Andersen K. J., Nordgaard K., Julshamn K., Schjoensby H. Increased serum aluminum in patients with jaundice. N Engl J Med. 1979 Sep 27;301(13):728–729. doi: 10.1056/nejm197909273011319. [DOI] [PubMed] [Google Scholar]
  18. Anderson F. H., Richardson E. P., Jr, Okazaki H., Brody J. A. Neurofibrillary degeneration on Guam: frequency in Chamorros and non Chamorros with no known neurological disease. Brain. 1979 Mar;102(1):65–77. doi: 10.1093/brain/102.1.65. [DOI] [PubMed] [Google Scholar]
  19. Anderson R. A., Brantner J. H., Polansky M. M. An improved assay for biologically active chromium. J Agric Food Chem. 1978 Sep-Oct;26(5):1219–1221. doi: 10.1021/jf60219a022. [DOI] [PubMed] [Google Scholar]
  20. Anderson R. A. Nutritional role of chromium. Sci Total Environ. 1981 Jan;17(1):13–29. doi: 10.1016/0048-9697(81)90104-2. [DOI] [PubMed] [Google Scholar]
  21. Anderson R. A., Polansky M. M., Bryden N. A., Patterson K. Y., Veillon C., Glinsmann W. H. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr. 1983 Feb;113(2):276–281. doi: 10.1093/jn/113.2.276. [DOI] [PubMed] [Google Scholar]
  22. Ando A., Ando I., Takeshita M., Hiraki T., Hisada K. Subcellular distribution of 111In and 169Yb in tumor and liver. Eur J Nucl Med. 1981;6(5):221–226. doi: 10.1007/BF00290567. [DOI] [PubMed] [Google Scholar]
  23. Andreoli S. P., Bergstein J. M., Sherrard D. J. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med. 1984 Apr 26;310(17):1079–1084. doi: 10.1056/NEJM198404263101704. [DOI] [PubMed] [Google Scholar]
  24. Antel J. P., Oger J. J., Dropcho E., Richman D. P., Kuo H. H., Arnason B. G. Reduced T-lymphocyte cell reactivity as a function of human aging. Cell Immunol. 1980 Aug 15;54(1):184–192. doi: 10.1016/0008-8749(80)90200-2. [DOI] [PubMed] [Google Scholar]
  25. Appel S. H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol. 1981 Dec;10(6):499–505. doi: 10.1002/ana.410100602. [DOI] [PubMed] [Google Scholar]
  26. Aprile M. A., Wardlaw A. C. Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health. 1966 Aug;57(8):343–360. [PubMed] [Google Scholar]
  27. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol. 1983;61(2):101–108. doi: 10.1007/BF00697388. [DOI] [PubMed] [Google Scholar]
  28. Arieff A. I., Cooper J. D., Armstrong D., Lazarowitz V. C. Dementia, renal failure, and brain aluminum. Ann Intern Med. 1979 May;90(5):741–747. doi: 10.7326/0003-4819-90-5-741. [DOI] [PubMed] [Google Scholar]
  29. Armbrustmacher V. W. Pathology of dementia. Pathol Annu. 1979;14(Pt 1):145–173. [PubMed] [Google Scholar]
  30. Arseneau J. C., Aamodt R., Johnston G. S., Canellos G. P. Evidence for granulocytic incorporation of 67gallium in chronic granulocytic leukemia. J Lab Clin Med. 1974 Mar;83(3):496–503. [PubMed] [Google Scholar]
  31. Aulbert E., Gebhardt A., Schulz E., Haubold U. Mechanism of 67Ga accumulation in normal rat liver lysosomes. Nuklearmedizin. 1976 Aug;15(4):185–194. [PubMed] [Google Scholar]
  32. BAETJER A. M., DAMRON C., BUDACZ V. The distribution and retention of chromium in men and animals. AMA Arch Ind Health. 1959 Aug;20(2):136–150. [PubMed] [Google Scholar]
  33. BIENVENU P., NOFRE C., CIER A. [The comparative general toxicity of metal ions. Relation with the periodic classification]. C R Hebd Seances Acad Sci. 1963 Jan 21;256:1043–1044. [PubMed] [Google Scholar]
  34. BROWN J. R., MASTROMATTEO E., HORWOOD J. Zirconium lactate and barium zirconate. Acute toxicity and inhalation effects in experimental animals. Am Ind Hyg Assoc J. 1963 Mar-Apr;24:131–136. doi: 10.1080/00028896309342940. [DOI] [PubMed] [Google Scholar]
  35. BRUCER M., ANDREWS G. A., REHBOCK D. J., ROOT S. W., GRAY J. VIII. Autopsy studies of distribution of gallium. Radiology. 1953 Oct;61(4):590–595. [PubMed] [Google Scholar]
  36. BRUNER H. D., HAYES R. L., PERKINSON J. D., Jr X. Preliminary data on gallium. Radiology. 1953 Oct;61(4):602–613. [PubMed] [Google Scholar]
  37. BUTT E. M., NUSBAUM R. E., GILMOUR T. C., DIDIO S. L., SISTER MARIANO TRACE METAL LEVELS IN HUMAN SERUM AND BLOOD. Arch Environ Health. 1964 Jan;8:52–57. doi: 10.1080/00039896.1964.10663631. [DOI] [PubMed] [Google Scholar]
  38. Balcerzak S. P., Mintz D. H., Westerman M. P. Diabetes mellitus and idiopathic hemochromatosis. Am J Med Sci. 1968 Jan;255:53–62. doi: 10.1097/00000441-196801000-00010. [DOI] [PubMed] [Google Scholar]
  39. Ball M. J. Alzheimer's disease: a challenging enigma. Arch Pathol Lab Med. 1982 Apr;106(4):157–162. [PubMed] [Google Scholar]
  40. Ball M. J., Nuttall K. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia. Ann Neurol. 1980 May;7(5):462–465. doi: 10.1002/ana.410070512. [DOI] [PubMed] [Google Scholar]
  41. Ball M. J., Nuttall K. Topography of neurofibrillary tangles and granulovacuoles in hippocampi of patients with Down's syndrome: quantitative comparison with normal ageing and Alzheimer's disease. Neuropathol Appl Neurobiol. 1981 Jan-Feb;7(1):13–20. doi: 10.1111/j.1365-2990.1981.tb00228.x. [DOI] [PubMed] [Google Scholar]
  42. Ball M. J. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study. Acta Neuropathol. 1978 May 24;42(2):73–80. doi: 10.1007/BF00690970. [DOI] [PubMed] [Google Scholar]
  43. Baltrukiewicz Z., Marciniak M., Urbaniak B. Distribution and retention of indium113m in the organism of pregnant rats. Acta Physiol Pol. 1976 Mar-Apr;27(2):191–197. [PubMed] [Google Scholar]
  44. Baluarte H. J., Gruskin A. B., Hiner L. B., Foley C. M., Grover W. D. Encephalopathy in children with chronic renal failure. Proc Clin Dial Transplant Forum. 1977;7:95–98. [PubMed] [Google Scholar]
  45. Bamberger C. E., Botbol J., Cabrini R. L. Inhibiton of alkaline phosphatase by beryllium and aluminum. Arch Biochem Biophys. 1968 Jan;123(1):195–200. doi: 10.1016/0003-9861(68)90119-7. [DOI] [PubMed] [Google Scholar]
  46. Banta R. G., Markesbery W. R. Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology. 1977 Mar;27(3):213–216. doi: 10.1212/wnl.27.3.213. [DOI] [PubMed] [Google Scholar]
  47. Barden J. A., Curmi P. M., Dos Remedios C. G. Crystalline actin tubes. III. The interaction of scandium and yttrium with skeletal muscle actin. Biochim Biophys Acta. 1981 Nov 30;671(1):25–32. doi: 10.1016/0005-2795(81)90089-1. [DOI] [PubMed] [Google Scholar]
  48. Barker D. J., Gardner M. J., Power C. Incidence of diabetes amongst people aged 18-50 years in nine British towns: a collaborative study. Diabetologia. 1982 Jun;22(6):421–425. doi: 10.1007/BF00282583. [DOI] [PubMed] [Google Scholar]
  49. Barna B. P., Chiang T., Pillarisetti S. G., Deodhar S. D. Immunologic studies of experimental beryllium lung disease in the guinea pig. Clin Immunol Immunopathol. 1981 Sep;20(3):402–411. doi: 10.1016/0090-1229(81)90150-1. [DOI] [PubMed] [Google Scholar]
  50. Barratt L. J., Lawrence J. R. Dialysis-associated dementia. Aust N Z J Med. 1975 Feb;5(1):62–65. doi: 10.1111/j.1445-5994.1975.tb03257.x. [DOI] [PubMed] [Google Scholar]
  51. Beamish M. R., Brown E. B. A comparison of the behavior of 111In and 59Fe-labeled transferrin on incubation with human and rat reticulocytes. Blood. 1974 May;43(5):703–711. [PubMed] [Google Scholar]
  52. Beamish M. R., Brown E. B. The metabolism of transferrin-bound 111In and 59Fe in the rat. Blood. 1974 May;43(5):693–701. [PubMed] [Google Scholar]
  53. Beneke G., Ervig K., Schmitt W. Polyploidisierung und Heterochromatisierung von Sehnenzellkernen in Abhängigkeit vom Lebensalter. Beitr Pathol. 1970;141(1):19–32. [PubMed] [Google Scholar]
  54. Benett R. W., Persaud T. V., Moore K. L. Experimental studies on the effects of aluminum on pregnancy and fetal development. Anat Anz. 1975;138(5):365–378. [PubMed] [Google Scholar]
  55. Bergerioux C., Boisvert J. Rapid neutron activation method for the determination of minerals in milk. Int J Nucl Med Biol. 1979;6(2):128–131. doi: 10.1016/0047-0740(79)90011-1. [DOI] [PubMed] [Google Scholar]
  56. Berlyne G. M., Ben-Ari J., Pest D., Weinberger J., Stern M., Levine R., Gilmore G. R. Hyperaluminaemia from aluminum resins in renal failure. Lancet. 1970 Sep 5;2(7671):494–496. doi: 10.1016/s0140-6736(70)90113-3. [DOI] [PubMed] [Google Scholar]
  57. Berry J. P., Escaig F., Poupon M. F., Galle P. Localization of gallium in tumor cells. Electron microscopy, electron probe microanalysis and analytical ion microscopy. Int J Nucl Med Biol. 1983;10(4):199–204. doi: 10.1016/0047-0740(83)90079-7. [DOI] [PubMed] [Google Scholar]
  58. Bertholf R. L., Brown S., Renoe B. W., Wills M. R., Savory J. Improved determination of aluminum in serum by electrothermal atomic absorption spectrophotometry. Clin Chem. 1983 Jun;29(6):1087–1089. [PubMed] [Google Scholar]
  59. Bianchi C., Berti N., Grandi G. Cerebral and extracerebral amyloidosis in senile dementia of the Alzheimer type. Pathologica. 1980 Jan-Feb;72(1017):67–70. [PubMed] [Google Scholar]
  60. Bianchi V., Celotti L., Lanfranchi G., Majone F., Marin G., Montaldi A., Sponza G., Tamino G., Venier P., Zantedeschi A. Genetic effects of chromium compounds. Mutat Res. 1983 May-Jun;117(3-4):279–300. doi: 10.1016/0165-1218(83)90128-3. [DOI] [PubMed] [Google Scholar]
  61. Bird T. D. Myotonic dystrophy associated with Down syndrome (trisomy 21). Neurology. 1981 Apr;31(4):440–442. doi: 10.1212/wnl.31.4.440. [DOI] [PubMed] [Google Scholar]
  62. Bizzi A., Crane R. C., Autilio-Gambetti L., Gambetti P. Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci. 1984 Mar;4(3):722–731. doi: 10.1523/JNEUROSCI.04-03-00722.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Björkstén B., Bäck O., Gustavson K. H., Hallmans G., Hägglöf B., Tärnvik A. Zinc and immune function in Down's syndrome. Acta Paediatr Scand. 1980 Mar;69(2):183–187. doi: 10.1111/j.1651-2227.1980.tb07057.x. [DOI] [PubMed] [Google Scholar]
  64. Blake N. M., Kirk R. L., Wilson S. R., Garruto R. M., Gajdusek D. C., Gibbs C. J., Jr, Hoffman P. Search for a red cell enzyme or serum protein marker in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Am J Med Genet. 1983 Feb;14(2):299–305. doi: 10.1002/ajmg.1320140210. [DOI] [PubMed] [Google Scholar]
  65. Blotcky A. J., Hobson D., Leffler J. A., Rack E. P., Recker R. R. Determination of trace aluminum in urine by neutron activation analysis. Anal Chem. 1976 Jun;48(7):1084–1088. doi: 10.1021/ac60371a028. [DOI] [PubMed] [Google Scholar]
  66. Bodensteiner J. B., Engel A. G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology. 1978 May;28(5):439–446. doi: 10.1212/wnl.28.5.439. [DOI] [PubMed] [Google Scholar]
  67. Boller F., Mizutani T., Roessmann U., Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol. 1980 Apr;7(4):329–335. doi: 10.1002/ana.410070408. [DOI] [PubMed] [Google Scholar]
  68. Bonhaus D. W., McCormack K. M., Mayor G. H., Mattson J. C., Hook J. B. The effects of aluminum on microtubular integrity using in vitro and in vivo models. Toxicol Lett. 1980 Aug;6(3):141–147. doi: 10.1016/0378-4274(80)90182-4. [DOI] [PubMed] [Google Scholar]
  69. Boni U. D., Otvos A., Scott J. W., Crapper D. R. Neurofibrillary degeneration induced by systemic aluminum. Acta Neuropathol. 1976 Aug 16;35(4):285–294. [PubMed] [Google Scholar]
  70. Bowdler N. C., Beasley D. S., Fritze E. C., Goulette A. M., Hatton J. D., Hession J., Ostman D. L., Rugg D. J., Schmittdiel C. J. Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol Biochem Behav. 1979 Apr;10(4):505–512. doi: 10.1016/0091-3057(79)90225-9. [DOI] [PubMed] [Google Scholar]
  71. Bowen P., Lentle B. C., Jackson F. I., Percy J. S., Rigal W. M. Abnormal localisation of gallium-67 citrate in pseudohypertrophic muscular dystrophy. Lancet. 1977 Nov 19;2(8047):1072–1073. doi: 10.1016/s0140-6736(77)91901-8. [DOI] [PubMed] [Google Scholar]
  72. Boyce B. F., Eider H. Y., Fell S. G., Nicholson W. A., Smith G. D., Dempster D. W., Gray C. C., Boyle I. T. Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy. Scan Electron Microsc. 1981;(Pt 3):329–337. [PubMed] [Google Scholar]
  73. Boyce B. F., Fell G. S., Elder H. Y., Junor B. J., Elliot H. L., Beastall G., Fogelman I., Boyle I. T. Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet. 1982 Nov 6;2(8306):1009–1013. doi: 10.1016/s0140-6736(82)90049-6. [DOI] [PubMed] [Google Scholar]
  74. Boyd A. E., 3rd, Lebovitz H. E., Feldman J. M. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa. J Clin Endocrinol Metab. 1971 Nov;33(5):829–837. doi: 10.1210/jcem-33-5-829. [DOI] [PubMed] [Google Scholar]
  75. Bracco L., Antuono P., Amaducci L. Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy. Acta Neurol Scand. 1979 Aug;60(2):112–124. doi: 10.1111/j.1600-0404.1979.tb02958.x. [DOI] [PubMed] [Google Scholar]
  76. Bradley W. G., Krasin F. A new hypothesis of the etiology of amyotrophic lateral sclerosis. The DNA hypothesis. Arch Neurol. 1982 Nov;39(11):677–680. doi: 10.1001/archneur.1982.00510230003001. [DOI] [PubMed] [Google Scholar]
  77. Breland A. E., Jr, Currier R. D. Multiple sclerosis and amyotrophic lateral sclerosis in Mississippi. Neurology. 1967 Oct;17(10):1011–1016. doi: 10.1212/wnl.17.10.1011. [DOI] [PubMed] [Google Scholar]
  78. Brody J. A. An epidemiologist views senile dementia--facts and fragments. Am J Epidemiol. 1982 Feb;115(2):155–162. doi: 10.1093/oxfordjournals.aje.a113286. [DOI] [PubMed] [Google Scholar]
  79. Brody J. A., Edgar A. H., Gillespie M. M. Amyotrophic lateral sclerosis. No increase among US construction workers in Guam. JAMA. 1978 Aug 11;240(6):551–560. doi: 10.1001/jama.240.6.551. [DOI] [PubMed] [Google Scholar]
  80. Brown D. J. Effect of calcium and aluminum concentrations on the survival of brown trout (Salmo trutta) at low pH. Bull Environ Contam Toxicol. 1983 May;30(5):582–587. doi: 10.1007/BF01610178. [DOI] [PubMed] [Google Scholar]
  81. Brown R. G., Ash J. M., Verellen-Dumoulin C., Percy M. E., Chang L. S., Oss I., Fulford P. Gallium-67 citrate localization in carriers of Duchenne muscular dystrophy. Int J Nucl Med Biol. 1981;8(4):379–388. doi: 10.1016/0047-0740(81)90046-2. [DOI] [PubMed] [Google Scholar]
  82. Brownlee M., Spiro R. G. Biochemistry of the basement membrane in diabetes mellitus. Adv Exp Med Biol. 1979;124:141–156. doi: 10.1007/978-1-4684-8508-0_8. [DOI] [PubMed] [Google Scholar]
  83. Brun A., Dictor M. Encefalopati av Alzheimers typ vid dialysdemens. Lakartidningen. 1980 Jun 25;77(26-27):2429–2430. [PubMed] [Google Scholar]
  84. Brun A., Gustafson L., Mitelman F. Normal chromosome banding pattern in Alzheimer's disease. Gerontology. 1978;24(5):369–372. doi: 10.1159/000212273. [DOI] [PubMed] [Google Scholar]
  85. Bryson W. G., Goodall C. M. Differential toxicity and clearance kinetics of chromium(III) or (VI) in mice. Carcinogenesis. 1983 Dec;4(12):1535–1539. doi: 10.1093/carcin/4.12.1535. [DOI] [PubMed] [Google Scholar]
  86. Buchanan M. R., Ihle B. U., Dunn C. M. Haemodialysis related osteomalacia: a staining method to demonstrate aluminium. J Clin Pathol. 1981 Dec;34(12):1352–1354. doi: 10.1136/jcp.34.12.1352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Buckton K. E., Whalley L. J., Lee M., Christie J. E. Chromosome changes in Alzheimer's presenile dementia. J Med Genet. 1983 Feb;20(1):46–51. doi: 10.1136/jmg.20.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Buge A., Escourolle R., Poisson M., Gray F., Bleibel J. M., Jaudon M. C. Encéphalopathie progressive des dialysés: rôle de l'aluminium et étude neuropathologique. Une observation. Nouv Presse Med. 1979 Mar 17;8(13):1071–1074. [PubMed] [Google Scholar]
  89. Bugiani O., Ghetti B. Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder. Neurobiol Aging. 1982 Fall;3(3):209–222. doi: 10.1016/0197-4580(82)90041-0. [DOI] [PubMed] [Google Scholar]
  90. Bugiani O., Perdelli F., Salvarani S., Leonardi A., Mancardi G. L. Loss of striatal neurons in Parkinson's disease: a cytometric study. Eur Neurol. 1980;19(5):339–344. doi: 10.1159/000115172. [DOI] [PubMed] [Google Scholar]
  91. Burgio G. R., Ugazio A. G. Immunity in Down's syndrome. Eur J Pediatr. 1978 Apr 20;127(4):293–294. doi: 10.1007/BF00493546. [DOI] [PubMed] [Google Scholar]
  92. Burks J. S., Alfrey A. C., Huddlestone J., Norenberg M. D., Lewin E. A fatal encephalopathy in chronic haemodialysis patients. Lancet. 1976 Apr 10;1(7963):764–768. doi: 10.1016/s0140-6736(76)91608-1. [DOI] [PubMed] [Google Scholar]
  93. Burnel D., Hutin M. F., Netter P., Kessler M., Huriet C., Gaucher A. Intérêy du dosage de l'aluminium osseux par polarographie impulsionnelle. Pathol Biol (Paris) 1982 Jan;30(1):27–32. [PubMed] [Google Scholar]
  94. Burnel D., Hutin M. F., Netter P., Kessler M., Huriet C., Gaucher A. Intérêy du dosage de l'aluminium osseux par polarographie impulsionnelle. Pathol Biol (Paris) 1982 Jan;30(1):27–32. [PubMed] [Google Scholar]
  95. Burrows D. Chromium and the skin. Br J Dermatol. 1978 Nov;99(5):587–595. doi: 10.1111/j.1365-2133.1978.tb02032.x. [DOI] [PubMed] [Google Scholar]
  96. Byrd B. L., Watson E. E., Cloutier R. J., Hayes R. L. Effect of stable scandium on the long-term whole body retention of intravenously administered 46Sc citrate in the rat. Health Phys. 1975 Sep;29(3):375–379. doi: 10.1097/00004032-197509000-00001. [DOI] [PubMed] [Google Scholar]
  97. CAMPBELL I. R., CASS J. S., CHOLAK J., KEHOE R. A. Aluminum in the environment of man; a review of its hygienic status. AMA Arch Ind Health. 1957 May;15(5):359–448. [PubMed] [Google Scholar]
  98. CHENG K. K. Experimental studies on the mechanism of the zonal distribution of beryllium liver necrosis. J Pathol Bacteriol. 1956 Apr;71(2):265–276. doi: 10.1002/path.1700710202. [DOI] [PubMed] [Google Scholar]
  99. CHEVREMONT M., FIRKET H. Action of beryllium on cells cultivated in vitro; effect on mitosis. Nature. 1951 May 12;167(4254):772–772. doi: 10.1038/167772a0. [DOI] [PubMed] [Google Scholar]
  100. COCHRAN K. W., DOULL J., MAZUR M., DUBOIS K. P. Acute toxicity of zirconium, columbium, strontium, lanthanum, cesium, tantalum and yttrium. Arch Ind Hyg Occup Med. 1950 Jun;1(6):637–650. [PubMed] [Google Scholar]
  101. COLLINS R. J., FROMM P. O., COLLINGS W. D. Chromium excretion in the dog. Am J Physiol. 1961 Nov;201:795–798. doi: 10.1152/ajplegacy.1961.201.5.795. [DOI] [PubMed] [Google Scholar]
  102. CURTIS G. H. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol. 1951 Oct;64(4):470–482. doi: 10.1001/archderm.1951.01570100087014. [DOI] [PubMed] [Google Scholar]
  103. Callery R. T., Strelkauskas A. J., Yanovich S., Marks S., Rosenthal D., Schlossman S. F. Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukemia. Clin Immunol Immunopathol. 1980 Nov;17(3):451–458. doi: 10.1016/0090-1229(80)90116-6. [DOI] [PubMed] [Google Scholar]
  104. Calne D. B., Duvoisin R. C., McGeer E. Speculations on the etiology of Parkinson's disease. Adv Neurol. 1984;40:353–360. [PubMed] [Google Scholar]
  105. Cameron I. L., Sparks R. L., Horn K. L., Smith N. R. Concentration of elements in mitotic chromatin as measured by x-ray microanalysis. J Cell Biol. 1977 Apr;73(1):193–199. doi: 10.1083/jcb.73.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Cann C. E., Prussin S. G., Gordan G. S. Aluminum uptake by the parathyroid glands. J Clin Endocrinol Metab. 1979 Oct;49(4):543–545. doi: 10.1210/jcem-49-4-543. [DOI] [PubMed] [Google Scholar]
  107. Cann C. E., Prussin S. G. Possible parathyroid imaging using Ga-67 and other aluminum analogs. J Nucl Med. 1980 May;21(5):471–474. [PubMed] [Google Scholar]
  108. Carlisle E. M. Proceedings: Silicon as an essential element. Fed Proc. 1974 Jun;33(6):1758–1766. [PubMed] [Google Scholar]
  109. Carter J. P., Kattab A., Abd-el-Hadi K., Davis J. T., el Gholmy A., Patwardhan V. N. Chromium (3) in hypoglycemia and in impaired glucose utilization in kwashiorkor. Am J Clin Nutr. 1968 Mar;21(3):195–202. doi: 10.1093/ajcn/21.3.195. [DOI] [PubMed] [Google Scholar]
  110. Casey C. E., Hambidge K. M. Chromium in human milk from American mothers. Br J Nutr. 1984 Jul;52(1):73–77. doi: 10.1079/bjn19840072. [DOI] [PubMed] [Google Scholar]
  111. Castronovo F. P., Wagner H. N. Factors affecting the toxicity of the element indium. Br J Exp Pathol. 1971 Oct;52(5):543–559. [PMC free article] [PubMed] [Google Scholar]
  112. Ceuppens J., Stevens E. Immunological aspects of sarcoidosis: review. Acta Clin Belg. 1978;33(2):78–97. doi: 10.1080/22953337.1978.11718622. [DOI] [PubMed] [Google Scholar]
  113. Chan Y. L., Alfrey A. C., Posen S., Lissner D., Hills E., Dunstan C. R., Evans R. A. Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int. 1983 May;35(3):344–351. doi: 10.1007/BF02405056. [DOI] [PubMed] [Google Scholar]
  114. Chen D. C., Scheffel U., Camargo E. E., Tsan M. F. The source of gallium-67 in gastrointestinal contents: concise communication. J Nucl Med. 1980 Dec;21(12):1146–1150. [PubMed] [Google Scholar]
  115. Chen K. M., Brody J. A., Kurland L. T. Patterns of neurologic diseases on guam. Arch Neurol. 1968 Dec;19(6):573–578. doi: 10.1001/archneur.1968.00480060043005. [DOI] [PubMed] [Google Scholar]
  116. Chen L. Neurofibrillary change on Guam. Arch Neurol. 1981 Jan;38(1):16–18. doi: 10.1001/archneur.1981.00510010042006. [DOI] [PubMed] [Google Scholar]
  117. Chen N. S., Tsai A., Dyer I. A. Effect of chelating agents on chromium absorption in rats. J Nutr. 1973 Aug;103(8):1182–1186. doi: 10.1093/jn/103.8.1182. [DOI] [PubMed] [Google Scholar]
  118. Cikrt M., Bencko V. Biliary excretion of 7Be and its distribution after intravenous administration of 7BeCl2 in rats. Arch Toxicol. 1975 Sep 5;34(1):53–60. doi: 10.1007/BF00353339. [DOI] [PubMed] [Google Scholar]
  119. Clarkson E. M., Luck V. A., Hynson W. V., Bailey R. R., Eastwood J. B., Woodhead J. S., Clements V. R., O'Riordan J. L., De Wardener H. E. The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. Clin Sci. 1972 Oct;43(4):519–531. doi: 10.1042/cs0430519. [DOI] [PubMed] [Google Scholar]
  120. Clemmensen O., Knudsen H. E. Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Dermatitis. 1980 Aug;6(5):305–308. doi: 10.1111/j.1600-0536.1980.tb04953.x. [DOI] [PubMed] [Google Scholar]
  121. Cloutier M. C., Fajans S. S. Familial patterns of inheritance of diabetes mellitus. Maturity-onset type diabetes of young people (MODY). Adv Exp Med Biol. 1979;119:59–65. doi: 10.1007/978-1-4615-9110-8_10. [DOI] [PubMed] [Google Scholar]
  122. Cochran M., Coates J., Neoh S. The competitive equilibrium between aluminium and ferric ions for the binding sites of transferrin. FEBS Lett. 1984 Oct 15;176(1):129–132. doi: 10.1016/0014-5793(84)80926-6. [DOI] [PubMed] [Google Scholar]
  123. Cochran M., Neoh S., Stephens E. Aluminium interaction with 67Ga uptake by human plasma and transferrin. Clin Chim Acta. 1983 Aug 15;132(2):199–203. doi: 10.1016/0009-8981(83)90248-6. [DOI] [PubMed] [Google Scholar]
  124. Cohen D., Eisdorfer C., Walford R. L. Histocompatibility antigens (HLA) and patterns of cognitive loss in dementia of the Alzheimer type. Neurobiol Aging. 1981 Winter;2(4):277–280. doi: 10.1016/0197-4580(81)90035-x. [DOI] [PubMed] [Google Scholar]
  125. Cohen H. A. The role of carrier in sensitivity to chromium and cobalt. Arch Dermatol. 1976 Jan;112(1):37–39. [PubMed] [Google Scholar]
  126. Cook R. H., Austin J. H. Precautions in familial transmissible dementia: including familial Alzheimer's disease. Arch Neurol. 1978 Nov;35(11):697–698. doi: 10.1001/archneur.1978.00500350001001. [DOI] [PubMed] [Google Scholar]
  127. Cook R. H., Ward B. E., Austin J. H. Studies in aging of the brain: IV. Familial Alzheimer disease: Relation to transmissible dementia, aneuploidy, and microtubular defects. Neurology. 1979 Oct;29(10):1402–1412. doi: 10.1212/wnl.29.10.1402. [DOI] [PubMed] [Google Scholar]
  128. Cournot-Witmer G., Zingraff J., Plachot J. J., Escaig F., Lefèvre R., Boumati P., Bourdeau A., Garabédian M., Galle P., Bourdon R. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int. 1981 Sep;20(3):375–378. doi: 10.1038/ki.1981.149. [DOI] [PubMed] [Google Scholar]
  129. Crapper D. R., Dalton A. J. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Physiol Behav. 1973 May;10(5):935–945. doi: 10.1016/0031-9384(73)90064-4. [DOI] [PubMed] [Google Scholar]
  130. Crapper D. R., DeBoni U. Brain aging and Alzheimer's disease. Can Psychiatr Assoc J. 1978 Jan;23(4):229–233. doi: 10.1177/070674377802300406. [DOI] [PubMed] [Google Scholar]
  131. Crapper D. R., Krishnan S. S., Dalton A. J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science. 1973 May 4;180(4085):511–513. doi: 10.1126/science.180.4085.511. [DOI] [PubMed] [Google Scholar]
  132. Crapper D. R., Krishnan S. S., De Boni U., Tomko G. J. Aluminum: a possible neurotoxic agent in Alzheimer's disease. Trans Am Neurol Assoc. 1975;100:154–156. [PubMed] [Google Scholar]
  133. Crapper D. R., Krishnan S. S., Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain. 1976 Mar;99(1):67–80. doi: 10.1093/brain/99.1.67. [DOI] [PubMed] [Google Scholar]
  134. Crapper D. R., Quittkat S., Krishnan S. S., Dalton A. J., De Boni U. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathol. 1980;50(1):19–24. doi: 10.1007/BF00688530. [DOI] [PubMed] [Google Scholar]
  135. Crapper D. R., Quittkat S., de Boni U. Altered chromatin conformation in Alzheimer's disease. Brain. 1979 Sep;102(3):483–495. doi: 10.1093/brain/102.3.483. [DOI] [PubMed] [Google Scholar]
  136. Crapper D. R., Tomko G. J. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration. Brain Res. 1975 Oct 31;97(2):253–264. doi: 10.1016/0006-8993(75)90448-5. [DOI] [PubMed] [Google Scholar]
  137. Cronan C. S., Schofield C. L. Aluminum leaching response to Acid precipitation: effects on high-elevation watersheds in the northeast. Science. 1979 Apr 20;204(4390):304–306. doi: 10.1126/science.204.4390.304. [DOI] [PubMed] [Google Scholar]
  138. Crossen P. E., Morgan W. F. Lymphocyte proliferation in Down's syndrome measured by sister chromatid differential staining. Hum Genet. 1980;53(3):311–313. doi: 10.1007/BF00287048. [DOI] [PubMed] [Google Scholar]
  139. DUDLEY H. C. Influence of chelates on the metabolism of radioyttrium (Y-90). J Lab Clin Med. 1955 May;45(5):792–799. [PubMed] [Google Scholar]
  140. Dahl D., Bignami A., Bich N. T., Chi N. H. Immunohistochemical characterization of neurofibrillary tangles induced by mitotic spindle inhibitors. Acta Neuropathol. 1980;51(2):165–168. doi: 10.1007/BF00690460. [DOI] [PubMed] [Google Scholar]
  141. Dahl D., Bignami A. Immunochemical cross-reactivity of normal neurofibrils and aluminum-induced neurofibrillary tangles. Immunofluorescence study with antineurofilament serum. Exp Neurol. 1978 Jan 1;58(1):74–80. doi: 10.1016/0014-4886(78)90122-x. [DOI] [PubMed] [Google Scholar]
  142. Dahl D., Nguyen B. T., Bignami A. Ultrastructural localization of neurofilament proteins in aluminum-induced neurofibrillary tangles and rat cerebellum by immunoperoxidase labeling. Dev Neurosci. 1982;5(1):54–63. doi: 10.1159/000112661. [DOI] [PubMed] [Google Scholar]
  143. Dahl D., Selkoe D. J., Pero R. T., Bignami A. Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum. J Neurosci. 1982 Jan;2(1):113–119. doi: 10.1523/JNEUROSCI.02-01-00113.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Danenberg K. D., Cleland W. W. Use of chromium-adenosine triphosphate and lyxose to elucidate the kinetic mechanism and coordination state of the nucleotide substrate for yeast hexokinase. Biochemistry. 1975 Jan 14;14(1):28–39. doi: 10.1021/bi00672a006. [DOI] [PubMed] [Google Scholar]
  145. Daniele R. P., Dauber J. H., Rossman M. D. Immunologic abnormalities in sarcoidosis. Ann Intern Med. 1980 Mar;92(3):406–416. doi: 10.7326/0003-4819-92-3-406. [DOI] [PubMed] [Google Scholar]
  146. Dassin E., Eberlin A., Briere J., Dosne A. M., Najean Y. Metabolic fate of 111indium in the rat. Int J Nucl Med Biol. 1978 Mar;5(1):34–37. doi: 10.1016/0047-0740(78)90089-x. [DOI] [PubMed] [Google Scholar]
  147. Dastur D. K., Manghani D. K., Raghavendran K. V. Distribution and fate of 54Mn in the monkey: studies of differnnt parts of the central nervous system and other organs. J Clin Invest. 1971 Jan;50(1):9–20. doi: 10.1172/JCI106487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Davidson T. J., Hartmann H. A., Johnson P. C. RNA content and volume of motor neurons in amyotrophic lateral sclerosis. I. The cervical swelling. J Neuropathol Exp Neurol. 1981 Jan;40(1):32–36. [PubMed] [Google Scholar]
  149. Davis S., Rambotti P. Mitogen stimulation of chronic lymphocytic leukemic lymphocytes: defective phytohemagglutinin stimulation independent of immunologic cell surface markers. Blood. 1980 Aug;56(2):256–261. [PubMed] [Google Scholar]
  150. Dayan A. D., Ball M. J. Histometric observations on the metabolism of tangle-bearing neurons. J Neurol Sci. 1973 Aug;19(4):433–436. doi: 10.1016/0022-510x(73)90040-3. [DOI] [PubMed] [Google Scholar]
  151. De Boni U., McLachlan D. R. Senile dementia and Alzheimer's disease: a current view. Life Sci. 1980 Jul 7;27(1):1–14. doi: 10.1016/0024-3205(80)90013-2. [DOI] [PubMed] [Google Scholar]
  152. De Boni U., Scott J. W., Crapper D. R. Intracellular aluminum binding; a histochemical study. Histochemistry. 1974 Jun 26;40(1):31–37. doi: 10.1007/BF00490271. [DOI] [PubMed] [Google Scholar]
  153. De Roo M., Hoogmartens M., Van Der Schueren B., De Geest G. Autoradiographic study of tumor tracer accumulation in experimental infectious lesions. Int J Nucl Med Biol. 1978;5(2-3):100–104. doi: 10.1016/0047-0740(78)90036-0. [DOI] [PubMed] [Google Scholar]
  154. DePamphilis M. L., Cleland W. W. Preparation and properties of chromium (3)-nucleotide complexes for use in the study of enzyme mechanisms. Biochemistry. 1973 Sep 11;12(19):3714–3724. doi: 10.1021/bi00743a022. [DOI] [PubMed] [Google Scholar]
  155. DePirro R., Lauro R., Testa I., Ferretti I., De Martinis C., Dellatonio R. Decreased insulin receptors but normal glucose metabolism in Duchenne muscular dystrophy. Science. 1982 Apr 16;216(4543):311–313. doi: 10.1126/science.7063889. [DOI] [PubMed] [Google Scholar]
  156. Delaney J. F. Spinal fluid aluminum levels in patients with Alzheimer disease. Ann Neurol. 1979 Jun;5(6):580–581. doi: 10.1002/ana.410050615. [DOI] [PubMed] [Google Scholar]
  157. Dinsdale D., Bourdillon A. J. The ultrastructural localization of beryllium in biological samples by electron energy-loss spectrometry. Exp Mol Pathol. 1982 Jun;36(3):396–402. doi: 10.1016/0014-4800(82)90068-5. [DOI] [PubMed] [Google Scholar]
  158. Dinsdale D. Lysosomal involvement in beryllium phosphate toxicity. Br J Exp Pathol. 1982 Feb;63(1):103–108. [PMC free article] [PubMed] [Google Scholar]
  159. Donaldson D. L., Rennert O. M. Chromium (III) metabolism by the kidney. Ann Clin Lab Sci. 1981 Sep-Oct;11(5):377–385. [PubMed] [Google Scholar]
  160. Donaldson J., LaBella F. S., Gesser D. Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology. 1981 Jan;2(1):53–64. [PubMed] [Google Scholar]
  161. Donaldson R. M., Jr, Barreras R. F. Intestinal absorption of trace quantities of chromium. J Lab Clin Med. 1966 Sep;68(3):484–493. [PubMed] [Google Scholar]
  162. Drew R. T., Gupta B. N., Bend J. R., Hook G. E. Inhalation studies with a glycol complex of aluminum-chloride-hydroxide. Arch Environ Health. 1974 Jun;28(6):321–326. doi: 10.1080/00039896.1974.10666500. [DOI] [PubMed] [Google Scholar]
  163. Drew R. T., Gupta B. N., Bend J. R., Hook G. E. Inhalation studies with a glycol complex of aluminum-chloride-hydroxide. Arch Environ Health. 1974 Jun;28(6):321–326. doi: 10.1080/00039896.1974.10666500. [DOI] [PubMed] [Google Scholar]
  164. Drüeke T. Dialysis osteomalacia and aluminum intoxication. Nephron. 1980;26(5):207–210. doi: 10.1159/000181985. [DOI] [PubMed] [Google Scholar]
  165. Dubois K. P., Cochran K. W., Mazur M. Inhibition of Phosphatases by Beryllium and Antagonism of the Inhibition by Manganese. Science. 1949 Oct 21;110(2860):420–422. doi: 10.1126/science.110.2860.420. [DOI] [PubMed] [Google Scholar]
  166. Duckett S., Galle P., Escourolle R., Grey F. Présence d'aluminium et de magnésium au niveau des artères et du parenchyme cérébral de malades atteints de syndrome striatonigré: étude à la microsonde de Castaing. C R Acad Sci Hebd Seances Acad Sci D. 1976 Jun 21;282(23):2115–2117. [PubMed] [Google Scholar]
  167. Duckett S., Galle P., Kradin R. The relationship between Parkinson syndrome and vascular siderosis: an electron microprobe study. Ann Neurol. 1977 Sep;2(3):225–229. doi: 10.1002/ana.410020308. [DOI] [PubMed] [Google Scholar]
  168. Dunea G., Mahurkar S. D., Mamdani B., Smith E. C. Role of aluminum in dialysis dementia. Ann Intern Med. 1978 Apr;88(4):502–504. doi: 10.7326/0003-4819-88-4-502. [DOI] [PubMed] [Google Scholar]
  169. Dymock I. W., Cassar J., Pyke D. A., Oakley W. G., Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med. 1972 Feb;52(2):203–210. doi: 10.1016/0002-9343(72)90070-8. [DOI] [PubMed] [Google Scholar]
  170. EDWARDS C., OLSON K. B., HEGGEN G., GLENN J. Intracellular distribution of trace elements in liver tissue. Proc Soc Exp Biol Med. 1961 May;107:94–97. doi: 10.3181/00379727-107-26546. [DOI] [PubMed] [Google Scholar]
  171. EPSTEIN W. L. Contribution to the pathogenesis of zirconium granulomas in man. J Invest Dermatol. 1960 Mar;34:183–188. doi: 10.1038/jid.1960.28. [DOI] [PubMed] [Google Scholar]
  172. EPSTEIN W. L., SKAHEN J. R., KRASNOBROD H. Granulomatous hypersensitivity to zirconium: localization of allergen in tissue and its role in formation of epithelioid cells. J Invest Dermatol. 1962 Apr;38:223–232. doi: 10.1038/jid.1962.40. [DOI] [PubMed] [Google Scholar]
  173. Edelman R. Vaccine adjuvants. Rev Infect Dis. 1980 May-Jun;2(3):370–383. doi: 10.1093/clinids/2.3.370. [DOI] [PubMed] [Google Scholar]
  174. Edwards C. Q., Dadone M. M., Skolnick M. H., Kushner J. P. Hereditary haemochromatosis. Clin Haematol. 1982 Jun;11(2):411–435. [PubMed] [Google Scholar]
  175. Eldridge R., Ryan E., Rosario J., Brody J. A. Amyotrophic lateral sclerosis and parkinsonism dementia in a migrant population from Guam. Neurology. 1969 Nov;19(11):1029–1037. doi: 10.1212/wnl.19.11.1029. [DOI] [PubMed] [Google Scholar]
  176. Elias Z., Schneider O., Aubry F., Daniere M. C., Poirot O. Sister chromatid exchanges in Chinese hamster V79 cells treated with the trivalent chromium compounds chromic chloride and chromic oxide. Carcinogenesis. 1983;4(5):605–611. doi: 10.1093/carcin/4.5.605. [DOI] [PubMed] [Google Scholar]
  177. Elizan T. S., Hirano A., Abrams B. M., Need R. L., Van Nuis C., Kurland L. T. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation. Arch Neurol. 1966 Apr;14(4):356–368. doi: 10.1001/archneur.1966.00470100012002. [DOI] [PubMed] [Google Scholar]
  178. Elliott H. L., Dryburgh F., Fell G. S., Sabet S., Macdougall A. I. Aluminium toxicity during regular haemodialysis. Br Med J. 1978 Apr 29;1(6120):1101–1103. doi: 10.1136/bmj.1.6120.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Elliott H. L., Macdougall A. I. Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc. 1978;15:157–163. [PubMed] [Google Scholar]
  180. Elliott H. L., Macdougall A. I. Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc. 1978;15:157–163. [PubMed] [Google Scholar]
  181. Elliott H. L., Macdougall A. I., Fell G. S. Aluminium toxicity syndrome. Lancet. 1978 Jun 3;1(8075):1203–1203. doi: 10.1016/s0140-6736(78)90991-1. [DOI] [PubMed] [Google Scholar]
  182. Elliott H. L., Macdougall A. I., Fell G. S., Gardiner P. H. Plasmapheresis, aluminium, and dialysis dementia. Lancet. 1978 Dec 9;2(8102):1255–1255. doi: 10.1016/s0140-6736(78)92128-1. [DOI] [PubMed] [Google Scholar]
  183. Ellis H. A., McCarthy J. H., Herrington J. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation. J Clin Pathol. 1979 Aug;32(8):832–844. doi: 10.1136/jcp.32.8.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Ellis H. A., Pierides A. M., Feest T. G., Ward M. K., Kerr D. N. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis. Clin Endocrinol (Oxf) 1977 Dec;7 (Suppl):31s–38s. doi: 10.1111/j.1365-2265.1977.tb03359.x. [DOI] [PubMed] [Google Scholar]
  185. Ellis W. G., McCulloch J. R., Corley C. L. Presenile dementia in Down's syndrome. Ultrastructural identity with Alzheimer's disease. Neurology. 1974 Feb;24(2):101–106. doi: 10.1212/wnl.24.2.101. [DOI] [PubMed] [Google Scholar]
  186. Embree L. J., Hamberger A., Sjöstrand J. Quantitative cytochemical studies and histochemistry in experimental neurofibrillary degeneration. J Neuropathol Exp Neurol. 1967 Jul;26(3):427–436. doi: 10.1097/00005072-196707000-00006. [DOI] [PubMed] [Google Scholar]
  187. Emery A. E., Burt D. Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Br Med J. 1980 Feb 9;280(6211):355–357. doi: 10.1136/bmj.280.6211.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Epstein L. B., Epstein C. J. T-lymphocyte function and sensitivity to interferon in trisomy 21. Cell Immunol. 1980 May;51(2):303–318. doi: 10.1016/0008-8749(80)90262-2. [DOI] [PubMed] [Google Scholar]
  189. Epstein W. L. Methal-induced granulomatous hypersensitivity in man. Adv Biol Skin. 1971;11:313–335. [PubMed] [Google Scholar]
  190. Evans J. A., Hunter A. G., Hamerton J. L. Down syndrome and recent demographic trends in Manitoba. J Med Genet. 1978 Feb;15(1):43–47. doi: 10.1136/jmg.15.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. FELDMAN I., HAVILL J. R., NEUMAN W. F. The state of beryllium in blood plasma. Arch Biochem Biophys. 1953 Oct;46(2):443–453. doi: 10.1016/0003-9861(53)90215-x. [DOI] [PubMed] [Google Scholar]
  192. FERGUSON-SMITH M. A., HANDMAKER S. D. Observations on the satellited human chromosomes. Lancet. 1961 Mar 25;1(7178):638–640. doi: 10.1016/s0140-6736(61)91655-5. [DOI] [PubMed] [Google Scholar]
  193. FINCH S. C., FINCH C. A. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis. Medicine (Baltimore) 1955 Dec;34(4):381–430. doi: 10.1097/00005792-195512000-00001. [DOI] [PubMed] [Google Scholar]
  194. FORBES A. P., ENGEL E. The high incidence of diabetes mellitus in 41 patients with gonadal dysgenesis, and their close relatives. Metabolism. 1963 May;12:428–439. [PubMed] [Google Scholar]
  195. FULLMER H. M., SIEDLER H. D., KROOTH R. S., KURLAND L. T. A cutaneous disorder of connective tissue in amyotrophic lateral sclerosis. A histochemical study. Neurology. 1960 Aug;10:717–724. doi: 10.1212/wnl.10.8.717. [DOI] [PubMed] [Google Scholar]
  196. Farnell B. J., De Boni U., Crapper McLachlan D. R. Aluminum neurotoxicity in the absence of neurofibrillary degeneration in CA1 hippocampal pyramidal neurons in vitro. Exp Neurol. 1982 Nov;78(2):241–258. doi: 10.1016/0014-4886(82)90044-9. [DOI] [PubMed] [Google Scholar]
  197. Fedorova K. N., Yudina I. E. Lymphocyte interphase chromatin in healthy subjects, patients with Down's syndrome, and their parents and sibs. J Med Genet. 1982 Dec;19(6):427–432. doi: 10.1136/jmg.19.6.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Fekete G., Kulcsár G., Dán P., Nász I., Schuler D., Dobos M. Immunological and virological investigations in Down's syndrome. Eur J Pediatr. 1982 Feb;138(1):59–62. doi: 10.1007/BF00442331. [DOI] [PubMed] [Google Scholar]
  199. Felmus M. T., Patten B. M., Swanke L. Antecedent events in amyotrophic lateral sclerosis. Neurology. 1976 Feb;26(2):167–172. doi: 10.1212/wnl.26.2.167. [DOI] [PubMed] [Google Scholar]
  200. Ferm V. H., Carpenter S. J. Teratogenic and embryopathic effects of indium, gallium, and germanium. Toxicol Appl Pharmacol. 1970 Jan;16(1):166–170. doi: 10.1016/0041-008x(70)90172-9. [DOI] [PubMed] [Google Scholar]
  201. Ferm V. H. Protective effect of ferric dextran on the embryopathic action of indium. Experientia. 1970 Jun 15;26(6):633–634. doi: 10.1007/BF01898731. [DOI] [PubMed] [Google Scholar]
  202. Fernandez L. A., MacSween J. M., Langley G. R. Impaired T-cell responses in chronic lymphocytic leukemia: lack of suppressor cell effect. Clin Immunol Immunopathol. 1981 Feb;18(2):168–175. doi: 10.1016/0090-1229(81)90022-2. [DOI] [PubMed] [Google Scholar]
  203. Finch J. T., Klug A. Solenoidal model for superstructure in chromatin. Proc Natl Acad Sci U S A. 1976 Jun;73(6):1897–1901. doi: 10.1073/pnas.73.6.1897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Fischer T., Rystedt I. A case of contact sensitivity to aluminium. Contact Dermatitis. 1982 Sep;8(5):343–343. doi: 10.1111/j.1600-0536.1982.tb04247.x. [DOI] [PubMed] [Google Scholar]
  205. Fitzgerald P. H., Brehaut L. A. Depression of DNA synthesis and mitotic index by colchicine in cultured human lymphocytes. Exp Cell Res. 1970 Jan;59(1):27–31. doi: 10.1016/0014-4827(70)90619-1. [DOI] [PubMed] [Google Scholar]
  206. Fitzgerald P. H., McEwan C. M. Total aneuploidy and age-related sex chromosome aneuploidy in cultured lymphocytes of normal men and women. Hum Genet. 1977 Dec 23;39(3):329–337. doi: 10.1007/BF00295428. [DOI] [PubMed] [Google Scholar]
  207. Fleming L. W., Stewart W. k., Fell G. S., Halls D. J. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium. Clin Nephrol. 1982 May;17(5):222–227. [PubMed] [Google Scholar]
  208. Ford-Hutchinson A. W., Perkins D. J. 46 Scandium metabolism; binding to metalloproteins in vivo and in vitro. Radiat Res. 1972 Aug;51(2):244–248. [PubMed] [Google Scholar]
  209. Ford-Hutchinson A. W., Perkins D. J. The binding of scandium ions to transferrin in vivo and in vitro. Eur J Biochem. 1971 Jul 15;21(1):55–59. doi: 10.1111/j.1432-1033.1971.tb01439.x. [DOI] [PubMed] [Google Scholar]
  210. Forno L. S., Norville R. L. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol. 1976 Mar 30;34(3):183–197. doi: 10.1007/BF00688674. [DOI] [PubMed] [Google Scholar]
  211. Franceschi C., Licastro F., Paolucci P., Masi M., Cavicchi S., Zannotti M. T and B lypmhocyte subpopulations in Down's syndrome. A study on non-institutionalised subjects. J Ment Defic Res. 1978 Sep;22(3):179–191. doi: 10.1111/j.1365-2788.1978.tb00975.x. [DOI] [PubMed] [Google Scholar]
  212. Frech W., Cedergren A., Cederberg C., Vessman J. Evaluation of some critical factors affecting determination of aluminum in blood, plasma, or serum by electrothermal atomic absorption spectroscopy. Clin Chem. 1982 Nov;28(11):2259–2263. [PubMed] [Google Scholar]
  213. Fuchs C., Brasche M., Donath U., Henning H. V., Knoll D., Nordbeck H., Paschen K., Quellhorst E., Scheler F. Flammenlose Atomabsorption zur Spurenelementanalyse in biologischen Materialien--Aluminiumbestimmungen nach Aludrox-Gabe bei Niereninsuffizienz. Verh Dtsch Ges Inn Med. 1973;79:683–685. [PubMed] [Google Scholar]
  214. Fuchs C., Brasche M., Paschen K., Nordbeck H., Quellhorst E. Aluminium-Bestimmung im Serum mit flammenloser Atomabsorption. Clin Chim Acta. 1974 Mar;52(1):71–80. doi: 10.1016/0009-8981(74)90389-1. [DOI] [PubMed] [Google Scholar]
  215. GRAUL E. H., HUNDESHAGEN H. 90Y-Organverteilungsstudien unter besonderer Berücksichtigung des autoradiographischen und papierelektrophoretischen Nachweisverfahrens. Strahlentherapie. 1958 Jul;106(3):405–417. [PubMed] [Google Scholar]
  216. Gaafar S. M., Turk J. L. Granuloma formation in lymph-nodes. J Pathol. 1970 Jan;100(1):9–20. doi: 10.1002/path.1711000103. [DOI] [PubMed] [Google Scholar]
  217. Gahrton G., Robèrt K. H. Chromosomal aberrations in chronic B-cell lymphocytic leukemia. Cancer Genet Cytogenet. 1982 Jun;6(2):171–181. doi: 10.1016/0165-4608(82)90082-6. [DOI] [PubMed] [Google Scholar]
  218. Gajdusek D. C. Foci of motor neuron disease in high incidence in isolated populations of East Asia and the Western Pacific. Adv Neurol. 1982;36:363–393. [PubMed] [Google Scholar]
  219. Gajdusek D. C., Salazar A. M. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology. 1982 Feb;32(2):107–126. doi: 10.1212/wnl.32.2.107. [DOI] [PubMed] [Google Scholar]
  220. Galle P., Berry J. P., Duckett S. Electron microprobe ultrastructural localization of aluminum in rat brain. Acta Neuropathol. 1980;49(3):245–247. doi: 10.1007/BF00707114. [DOI] [PubMed] [Google Scholar]
  221. Galle P., Campos H., Giudicelli C. Localisation ultrastructurale de l'aluminium dans les cellules parathyroïdiennes de malades en dialyse chronique. C R Seances Acad Sci III. 1983;296(12):545–550. [PubMed] [Google Scholar]
  222. Galle P., Chatel M., Berry J. P., Menault F. Encéphalopathie myoclonique progressive des dialysés: présence d'aluminium en forte concentration dans les lysosomes des cellules cérébrales. Nouv Presse Med. 1979 Dec 24;8(50):4091–4094. [PubMed] [Google Scholar]
  223. Galle P., Giudicelli C. P. Toxicité de l'aluminium pour l'hépatocyte. Localisation ultrastructurale et micro-analyse des dépôts. Nouv Presse Med. 1982 Apr 3;11(15):1123–1125. [PubMed] [Google Scholar]
  224. Galle P. Mécanisme d'élimination rénale de deux éléments du groupe IIIA de la classification périodique : l'aluminium et l'indium. C R Seances Acad Sci III. 1981 Jan 5;292(1):91–96. [PubMed] [Google Scholar]
  225. Galloway S. M., Buckton K. E. Aneuploidy and ageing: chromosome studies on a random sample of the population using G-banding. Cytogenet Cell Genet. 1978;20(1-6):78–95. doi: 10.1159/000130842. [DOI] [PubMed] [Google Scholar]
  226. Garruto R. M., Fukatsu R., Yanagihara R., Gajdusek D. C., Hook G., Fiori C. E. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1875–1879. doi: 10.1073/pnas.81.6.1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Garruto R. M., Gajdusek C., Chen K. M. Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann Neurol. 1980 Dec;8(6):612–619. doi: 10.1002/ana.410080612. [DOI] [PubMed] [Google Scholar]
  228. Garruto R. M., Gajdusek D. C., Chen K. M. Amyotrophic lateral sclerosis and parkinsonism-dementia among Filipino migrants to Guam. Ann Neurol. 1981 Oct;10(4):341–350. doi: 10.1002/ana.410100405. [DOI] [PubMed] [Google Scholar]
  229. Geary D. F., Fennell R. S., Andriola M., Gudat J., Rodgers B. M., Richard G. A. Encephalopathy in children with chronic renal failure. J Pediatr. 1980 Jul;97(1):41–44. doi: 10.1016/s0022-3476(80)80127-2. [DOI] [PubMed] [Google Scholar]
  230. Gedik O., Unal S., Koray Z. Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus. Isr J Med Sci. 1980 Aug;16(8):563–565. [PubMed] [Google Scholar]
  231. Gelb M. H., Harris D. C. Correlation of proton release and ultraviolet difference spectra associated with metal binding by transferrin. Arch Biochem Biophys. 1980 Mar;200(1):93–98. doi: 10.1016/0003-9861(80)90335-5. [DOI] [PubMed] [Google Scholar]
  232. Gelrud L. G., Arseneau J. C., Milder M. S., Kramer R. J., Swann S. J., Canellos G. P., Johnston G. S. The kinetics of 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med. 1974 Mar;83(3):489–495. [PubMed] [Google Scholar]
  233. Gentile J. M., Hyde K., Schubert J. Chromium genotoxicity as influenced by complexation and rate effects. Toxicol Lett. 1981 Mar;7(6):439–448. doi: 10.1016/0378-4274(81)90090-4. [DOI] [PubMed] [Google Scholar]
  234. Gershon H., Merhav S., Abraham C. T-cell division and aging. Mech Ageing Dev. 1979 Jan;9(1-2):27–38. doi: 10.1016/0047-6374(79)90118-0. [DOI] [PubMed] [Google Scholar]
  235. Ghafghazi T., Maghbareh A., Barnett R. Chromium-induced hyperglycemia in the rat. Toxicology. 1979 Jan;12(1):47–52. doi: 10.1016/0300-483x(79)90031-3. [DOI] [PubMed] [Google Scholar]
  236. Ghafghazi T., McDaniel M. L., Lacy P. E. Chromium-induced inhibition of insulin secretion from isolated islets of Langerhans. Diabetologia. 1980 Mar;18(3):229–232. doi: 10.1007/BF00251921. [DOI] [PubMed] [Google Scholar]
  237. Ghetti B., Gambetti P. Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies. Brain Res. 1983 Oct 16;276(2):388–393. doi: 10.1016/0006-8993(83)90754-0. [DOI] [PubMed] [Google Scholar]
  238. Gibbs C. J., Jr, Gajdusek D. C. Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology. J Clin Pathol Suppl (R Coll Pathol) 1972;6:132–140. [PMC free article] [PubMed] [Google Scholar]
  239. Gilli P., De Bastiani P., Fagioli F., Rosati G., Betti A., Farinelli A. Aluminium, EEG and intellectual function in patients on regular dialysis treatment (RDT). Proc Eur Dial Transplant Assoc. 1979;16:663–664. [PubMed] [Google Scholar]
  240. Gilli P., Fagioli F., Malacarne F., Bedani P. L., Buoncristiani U., Carobi C., Locatelli F., Farinelli A. Serum aluminum levels and peritoneal dialysis. Int J Artif Organs. 1984 Mar;7(2):107–110. [PubMed] [Google Scholar]
  241. Goldblum S. E., Reed W. P. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 1980 Oct;93(4):597–613. doi: 10.7326/0003-4819-93-4-597. [DOI] [PubMed] [Google Scholar]
  242. Goldblum S. E., Reed W. P. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 1980 Oct;93(4):597–613. doi: 10.7326/0003-4819-93-4-597. [DOI] [PubMed] [Google Scholar]
  243. Goldman J. E., Yen S. H., Chiu F. C., Peress N. S. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science. 1983 Sep 9;221(4615):1082–1084. doi: 10.1126/science.6308771. [DOI] [PubMed] [Google Scholar]
  244. Goldsmith B. M., Gruemer H. D., Hawley R. J., Pickard N. A., Verrill H. L., Nance W. E., Miller G., Crawford R. G. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait. Clin Chem. 1980 May;26(6):754–759. [PubMed] [Google Scholar]
  245. Gooddy W., Williams T. R., Nicholas D. Spark-source mass spectrometry in the investigation of neurological disease. Brain. 1974 Jun;97(2):327–336. doi: 10.1093/brain/97.1.327. [DOI] [PubMed] [Google Scholar]
  246. Gormican A. Inorganic elements in foods used in hospital menus. J Am Diet Assoc. 1970 May;56(5):397–403. [PubMed] [Google Scholar]
  247. Gorsky J. E., Dietz A. A. Aluminum concentrations in serum of hemodialysis patients. Clin Chem. 1981 Jun;27(6):932–935. [PubMed] [Google Scholar]
  248. Gorsky J. E., Dietz A. A. Determination of aluminum in biological samples by atomic absorption spectrophotometry with a graphite furnace. Clin Chem. 1978 Sep;24(9):1485–1490. [PubMed] [Google Scholar]
  249. Gorsky J. E., Dietz A. A., Spencer H., Osis D. Metabolic balance of aluminum studied in six men. Clin Chem. 1979 Oct;25(10):1739–1743. [PubMed] [Google Scholar]
  250. Goto F., Kitamura A., Koto A., Kataoka K., Atsuji H. Abnormal insulin secretion in amyotrophic lateral sclerosis. J Neurol Sci. 1972 Jun;16(2):201–207. doi: 10.1016/0022-510x(72)90089-5. [DOI] [PubMed] [Google Scholar]
  251. Goudsmit J., Morrow C. H., Asher D. M., Yanagihara R. T., Masters C. L., Gibbs C. J., Jr, Gajdusek D. C. Evidence for and against the transmissibility of Alzheimer disease. Neurology. 1980 Sep;30(9):945–950. doi: 10.1212/wnl.30.9.945. [DOI] [PubMed] [Google Scholar]
  252. Graber S. E., Hurley P. J., Heyssel R. M., McIntyre P. A. Behavior of iron-, indium-, and iodine-labeled transferrin. Proc Soc Exp Biol Med. 1970 Mar;133(3):1093–1096. doi: 10.3181/00379727-133-34631. [DOI] [PubMed] [Google Scholar]
  253. Graf H., Stummvoll H. K., Meisinger V., Kovarik J., Wolf A., Pinggera W. F. Aluminum removal by hemodialysis. Kidney Int. 1981 Apr;19(4):587–592. doi: 10.1038/ki.1981.56. [DOI] [PubMed] [Google Scholar]
  254. Green R., Charlton R., Seftel H., Bothwell T., Mayet F., Adams B., Finch C., Layrisse M. Body iron excretion in man: a collaborative study. Am J Med. 1968 Sep;45(3):336–353. doi: 10.1016/0002-9343(68)90069-7. [DOI] [PubMed] [Google Scholar]
  255. Greene W. C., Parker C. M., Parker C. W. Colchicine-sensitive structures and lymphocyte activation. J Immunol. 1976 Sep;117(3):1015–1022. [PubMed] [Google Scholar]
  256. Greger J. L., Baier M. J. Excretion and retention of low or moderate levels of aluminium by human subjects. Food Chem Toxicol. 1983 Aug;21(4):473–477. doi: 10.1016/0278-6915(83)90105-9. [DOI] [PubMed] [Google Scholar]
  257. Grell R. F. Origin of meiotic nondisjunction in Drosophila females. Environ Health Perspect. 1979 Aug;31:33–39. doi: 10.1289/ehp.793133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Griswold W. R., Reznik V., Mendoza S. A., Trauner D., Alfrey A. C. Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatrics. 1983 Jan;71(1):56–58. [PubMed] [Google Scholar]
  259. Groth D. H. Carcinogenicity of beryllium: review of the literature. Environ Res. 1980 Feb;21(1):56–62. doi: 10.1016/0013-9351(80)90008-0. [DOI] [PubMed] [Google Scholar]
  260. Gruenberg E. M. Epidemiology of senile dementia. Adv Neurol. 1978;19:437–457. [PubMed] [Google Scholar]
  261. Grundke-Iqbal I., Johnson A. B., Terry R. D., Wisniewski H. M., Iqbal K. Alzheimer neurofibrillary tangles: antiserum and immunohistological staining. Ann Neurol. 1979 Dec;6(6):532–537. doi: 10.1002/ana.410060612. [DOI] [PubMed] [Google Scholar]
  262. Grünzig G., Lücker P. W., Schnitker J. Serum- und Urin-Elektrolytverhalten unter therapeutischer Dosierung eines potenten Magnesium- und Aluminiumhydroxid-haltigen Antazidums. Arzneimittelforschung. 1983;33(2):258–262. [PubMed] [Google Scholar]
  263. Guthrie B. E., Wolf W. R., Veillon C. Background correction and related problems in the determination of chromium in urine by graphite furnace atomic absorption spectrometry. Anal Chem. 1978 Nov;50(13):1900–1902. doi: 10.1021/ac50035a043. [DOI] [PubMed] [Google Scholar]
  264. HADDOW A., HORNING E. S. On the carcinogenicity of an iron-dextran complex. J Natl Cancer Inst. 1960 Jan;24:109–147. [PubMed] [Google Scholar]
  265. HALEY T. J., KOMESU N., MAVIS L., CAWTHORNE J., UPHAM H. C. Pharmacology and toxicology of scandium chloride. J Pharm Sci. 1962 Nov;51:1043–1045. doi: 10.1002/jps.2600511107. [DOI] [PubMed] [Google Scholar]
  266. HIRANO A., KURLAND L. T., KROOTH R. S., LESSELL S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain. 1961 Dec;84:642–661. doi: 10.1093/brain/84.4.642. [DOI] [PubMed] [Google Scholar]
  267. HIRANO A., MALAMUD N., KURLAND L. T. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. Brain. 1961 Dec;84:662–679. doi: 10.1093/brain/84.4.662. [DOI] [PubMed] [Google Scholar]
  268. HOPKINS L. L., Jr, SCHWARZ K. CHROMIUM (3) BINDING TO SERUM PROTEINS, SPECIFICALLY SIDEROPHILIN. Biochim Biophys Acta. 1964 Sep 4;90:484–491. doi: 10.1016/0304-4165(64)90228-4. [DOI] [PubMed] [Google Scholar]
  269. HOPKINS L. L., Jr, SCHWARZ K. CHROMIUM (3) BINDING TO SERUM PROTEINS, SPECIFICALLY SIDEROPHILIN. Biochim Biophys Acta. 1964 Sep 4;90:484–491. doi: 10.1016/0304-4165(64)90228-4. [DOI] [PubMed] [Google Scholar]
  270. Hakim A. M., Mathieson G. Dementia in Parkinson disease: a neuropathologic study. Neurology. 1979 Sep;29(9 Pt 1):1209–1214. doi: 10.1212/wnl.29.9_part_1.1209. [DOI] [PubMed] [Google Scholar]
  271. Hall J. G., Spencer J. Studies on the adjuvant action of beryllium. II. Systemic effects with particular reference to secretory immunity. Immunology. 1984 Sep;53(1):115–120. [PMC free article] [PubMed] [Google Scholar]
  272. Hamilton E. I. Aluminium and Alzheimer's disease -- a comment. Sci Total Environ. 1982 Sep;25(1):87–91. doi: 10.1016/0048-9697(82)90046-8. [DOI] [PubMed] [Google Scholar]
  273. Hammer R. P., Jr, Tomiyasu U., Scheibel A. B. Degeneration of the human Betz cell due to amyotrophic lateral sclerosis. Exp Neurol. 1979 Feb;63(2):336–346. doi: 10.1016/0014-4886(79)90129-8. [DOI] [PubMed] [Google Scholar]
  274. Handmaker H., O'Mara R. E. Gallium imaging in pediatrics. J Nucl Med. 1977 Nov;18(11):1057–1063. [PubMed] [Google Scholar]
  275. Hanna N., Blanc S., Nelken D. Adjuvant-induced nonspecific supressor cells: in vitro and in vivo studies. Cell Immunol. 1980 Aug 1;53(2):225–235. doi: 10.1016/0008-8749(80)90324-x. [DOI] [PubMed] [Google Scholar]
  276. Hanna N., Blanc S., Nelken D. Adjuvant-induced nonspecific supressor cells: in vitro and in vivo studies. Cell Immunol. 1980 Aug 1;53(2):225–235. doi: 10.1016/0008-8749(80)90324-x. [DOI] [PubMed] [Google Scholar]
  277. Hansson A. Satellite association in human metaphases. A comparative study of normal individuals, patients with Down syndrome and their parents. Hereditas. 1979;90(1):59–83. doi: 10.1111/j.1601-5223.1979.tb01294.x. [DOI] [PubMed] [Google Scholar]
  278. Hanyu N., Oguchi K., Yanagisawa N., Tsukagoshi H. Degeneration and regeneration of ventral root motor fibers in amyotrophic lateral sclerosis. Morphometric studies of cervical ventral roots. J Neurol Sci. 1982 Jul;55(1):99–115. doi: 10.1016/0022-510x(82)90173-3. [DOI] [PubMed] [Google Scholar]
  279. Hara T., Freed B. R. Preparation of carrier-free 47 Sc by chemical separation from 47 Ca and its distribution in tumor bearing mice. Int J Appl Radiat Isot. 1973 Jul;24(7):373–376. doi: 10.1016/0020-708x(73)90016-1. [DOI] [PubMed] [Google Scholar]
  280. Hard G. C., Skilleter D. N., Reiner E. Correlation of pathology with distribution of Be following administration of beryllium sulfate and beryllium sulfosalicylate complexes to the rat. Exp Mol Pathol. 1977 Oct;27(2):197–212. doi: 10.1016/0014-4800(77)90030-2. [DOI] [PubMed] [Google Scholar]
  281. Harlan J. W., Feairheller S. H. Chemistry of the crosslinking of collagen during tanning. Adv Exp Med Biol. 1977;86A:425–440. doi: 10.1007/978-1-4684-3282-4_27. [DOI] [PubMed] [Google Scholar]
  282. Harris A. W., Sephton R. G. Transferrin promotion of 67Ga and 59Fe uptake by cultured mouse myeloma cells. Cancer Res. 1977 Oct;37(10):3634–3638. [PubMed] [Google Scholar]
  283. Harris D. C., Aisen P. Facilitation of Fe(II) autoxidation by Fe(3) complexing agents. Biochim Biophys Acta. 1973 Nov 2;329(1):156–158. doi: 10.1016/0304-4165(73)90019-6. [DOI] [PubMed] [Google Scholar]
  284. Harrison W. H., Codd E., Gray R. M. Aluminium inhibition of hexokinase. Lancet. 1972 Aug 5;2(7771):277–277. doi: 10.1016/s0140-6736(72)91707-2. [DOI] [PubMed] [Google Scholar]
  285. Harrison W. W., Clemena G. G. Survey analysis of trace elements in human fingernails by spark source mass spectrometry. Clin Chim Acta. 1972 Feb;36(2):485–492. doi: 10.1016/0009-8981(72)90024-1. [DOI] [PubMed] [Google Scholar]
  286. Hart B. A., Pittman D. G. The uptake of beryllium by the alveolar macrophage. J Reticuloendothel Soc. 1980 Jan;27(1):49–58. [PubMed] [Google Scholar]
  287. Hart M. M., Adamson R. H. Antitumor activity and toxicity of salts of inorganic group 3a metals: aluminum, gallium, indium, and thallium. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1623–1626. doi: 10.1073/pnas.68.7.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Hartmann H. A., Davidson T. J. Neuronal RNA in motor neuron disease. Adv Neurol. 1982;36:89–103. [PubMed] [Google Scholar]
  289. Haylock S. J., Buckley P. D., Blackwell L. F. The relationship of chromium to the glucose tolerance factor. II. J Inorg Biochem. 1983 Oct;19(2):105–117. doi: 10.1016/0162-0134(83)85016-8. [DOI] [PubMed] [Google Scholar]
  290. Heaf J. G., Nielsen L. P. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption. Miner Electrolyte Metab. 1984;10(6):345–350. [PubMed] [Google Scholar]
  291. Hegge F. N., Mahler D. J., Larson S. M. The incorporation of Ga-67 into the ferritin fraction of rabbit hepatocytes in vivo. J Nucl Med. 1977 Sep;18(9):937–939. [PubMed] [Google Scholar]
  292. Henry D. A., Goodman W. G., Nudelman R. K., DiDomenico N. C., Alfrey A. C., Slatopolsky E., Stanley T. M., Coburn J. W. Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. Kidney Int. 1984 Feb;25(2):362–369. doi: 10.1038/ki.1984.25. [DOI] [PubMed] [Google Scholar]
  293. Henry D. A., Goodman W. G., Nudelman R. K., DiDomenico N. C., Alfrey A. C., Slatopolsky E., Stanley T. M., Coburn J. W. Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. Kidney Int. 1984 Feb;25(2):362–369. doi: 10.1038/ki.1984.25. [DOI] [PubMed] [Google Scholar]
  294. Henschke P. J., Bell D. A., Cape R. D. Alzheimer's disease and HLA. Tissue Antigens. 1978 Aug;12(2):132–135. doi: 10.1111/j.1399-0039.1978.tb01308.x. [DOI] [PubMed] [Google Scholar]
  295. Heston L. L. Alzheimer's dementia and Down's syndrome: genetic evidence suggesting an association. Ann N Y Acad Sci. 1982;396:29–37. doi: 10.1111/j.1749-6632.1982.tb26841.x. [DOI] [PubMed] [Google Scholar]
  296. Heston L. L. Alzheimer's disease, trisomy 21, and myeloproliferative disorders: associations suggesting a genetic diathesis. Science. 1977 Apr 15;196(4287):322–323. doi: 10.1126/science.196.4287.322. [DOI] [PubMed] [Google Scholar]
  297. Heston L. L., Mastri A. R., Anderson V. E., White J. Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry. 1981 Oct;38(10):1085–1090. doi: 10.1001/archpsyc.1981.01780350019001. [DOI] [PubMed] [Google Scholar]
  298. Heston L. L., Mastri A. R. The genetics of Alzheimer's disease: associations with hematologic malignancy and Down's syndrome. Arch Gen Psychiatry. 1977 Aug;34(8):976–981. doi: 10.1001/archpsyc.1977.01770200114017. [DOI] [PubMed] [Google Scholar]
  299. Heyman A., Wilkinson W. E., Hurwitz B. J., Schmechel D., Sigmon A. H., Weinberg T., Helms M. J., Swift M. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol. 1983 Nov;14(5):507–515. doi: 10.1002/ana.410140503. [DOI] [PubMed] [Google Scholar]
  300. Ho A. D., Reitter B., Stojakowits S., Fiehn W., Weisser J. Capping of lymphocytes for carrier detection in Duchenne muscular dystrophy: technical problems and a review of the literature. Eur J Pediatr. 1980 Sep;134(3):211–216. doi: 10.1007/BF00441475. [DOI] [PubMed] [Google Scholar]
  301. Hodsman A. B., Sherrard D. J., Wong E. G., Brickman A. S., Lee D. B., Alfrey A. C., Singer F. R., Norman A. W., Coburn J. W. Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Intern Med. 1981 May;94(5):629–637. doi: 10.7326/0003-4819-94-5-629. [DOI] [PubMed] [Google Scholar]
  302. Hoehn M. M. Age distribution of patients with Parkinsonism. J Am Geriatr Soc. 1976 Feb;24(2):79–85. doi: 10.1111/j.1532-5415.1976.tb03294.x. [DOI] [PubMed] [Google Scholar]
  303. Hoffer P. B., Huberty J., Khayam-Bashi H. The association of Ga-67 and lactoferrin. J Nucl Med. 1977 Jul;18(7):713–717. [PubMed] [Google Scholar]
  304. Hoffer P. Status of gallium-67 in tumor detection. J Nucl Med. 1980 Apr;21(4):394–398. [PubMed] [Google Scholar]
  305. Hoffman P. M., Robbins D. S., Nolte M. T., Gibbs C. J., Jr, Gajdusek D. C. Cellular immunity in Guamanians with amyotrophic lateral sclerosis and Parkinsonism-dementia. N Engl J Med. 1978 Sep 28;299(13):680–685. doi: 10.1056/NEJM197809282991302. [DOI] [PubMed] [Google Scholar]
  306. Holloway S., Emery A. E. Factors affecting the incidence of Down syndrome in Scotland. J Biosoc Sci. 1977 Oct;9(4):453–465. doi: 10.1017/s0021932000011299. [DOI] [PubMed] [Google Scholar]
  307. Hopkins L. L., Jr Distribution in the rat of physiological amounts of injected Cr-51(3) with time. Am J Physiol. 1965 Oct;209(4):731–735. doi: 10.1152/ajplegacy.1965.209.4.731. [DOI] [PubMed] [Google Scholar]
  308. Horenstein A. L., Emery A. E. Human lymphocyte capping in Duchenne muscular dystrophy. Neurology. 1980 Dec;30(12):1330–1332. doi: 10.1212/wnl.30.12.1330. [DOI] [PubMed] [Google Scholar]
  309. Hosain F., McIntyre P. A., Poulose K., Stern H. S., Wagner H. N., Jr Binding of trace amounts of ionic indium-113m to plasma transferrin. Clin Chim Acta. 1969 Apr;24(1):69–75. doi: 10.1016/0009-8981(69)90142-9. [DOI] [PubMed] [Google Scholar]
  310. Houghton J. A. The study of chromosome non-disjunction in man. Ir J Med Sci. 1981 Dec;150(12):357–366. doi: 10.1007/BF02938274. [DOI] [PubMed] [Google Scholar]
  311. Hrapchak B. B. Selective staining with hematoxylin, applications and theory: a review. Am J Med Technol. 1976 Oct;42(10):371–379. [PubMed] [Google Scholar]
  312. Huber C. T., Frieden E. The inhibition of ferroxidase by trivalent and other metal ions. J Biol Chem. 1970 Aug 10;245(15):3979–3984. [PubMed] [Google Scholar]
  313. Hudson A. J. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain. 1981 Jun;104(2):217–247. doi: 10.1093/brain/104.2.217. [DOI] [PubMed] [Google Scholar]
  314. Huffman E. W., Jr, Allaway W. H. Chromium in plants: distribution in tissues, organelles, and extracts and availability of bean leaf Cr to animals. J Agric Food Chem. 1973 Nov-Dec;21(6):982–986. doi: 10.1021/jf60190a008. [DOI] [PubMed] [Google Scholar]
  315. Hurley J. N., Fu S. M., Kunkel H. G., Chaganti R. S., German J. Chromosome abnormalities of leukaemic B lymphocytes in chronic lymphocytic leukaemia. Nature. 1980 Jan 3;283(5742):76–78. doi: 10.1038/283076a0. [DOI] [PubMed] [Google Scholar]
  316. Hydes D. J. Aluminum in seawater: control by inorganic processes. Science. 1979 Sep 21;205(4412):1260–1262. doi: 10.1126/science.205.4412.1260. [DOI] [PubMed] [Google Scholar]
  317. Höck A., Demmel U., Schicha H., Kasperek K., Feinendegen L. E. Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain. 1975 Mar;98(1):49–64. doi: 10.1093/brain/98.1.49. [DOI] [PubMed] [Google Scholar]
  318. Ihle B., Buchanan M., Stevens B., Marshal A., Plomley R., d'Apice A., Kincaid-Smith P. Aluminum associated bone disease: clinico-pathologic correlation. Am J Kidney Dis. 1982 Sep;2(2):255–263. doi: 10.1016/s0272-6386(82)80071-1. [DOI] [PubMed] [Google Scholar]
  319. Iqbal K., Grundke-Iqbal I., Wisniewski H. M., Terry R. D. Chemical relationship of the paired helical filaments of Alzheimer's dementia to normal human neurofilaments and neurotubules. Brain Res. 1978 Feb 24;142(2):321–332. doi: 10.1016/0006-8993(78)90638-8. [DOI] [PubMed] [Google Scholar]
  320. Ishii T., Haga S., Tokutake S. Presence of neurofilament protein in Alzheimer's neurofibrillary tangles (ANT). An immunofluorescent study. Acta Neuropathol. 1979 Nov;48(2):105–112. doi: 10.1007/BF00691151. [DOI] [PubMed] [Google Scholar]
  321. Ivanov B., Praskova L., Mileva M., Bulanova M., Georgieva I. Spontaneous chromosomal aberration levels in human peripheral lymphocytes. Mutat Res. 1978 Dec;52(3):421–426. doi: 10.1016/0027-5107(78)90180-x. [DOI] [PubMed] [Google Scholar]
  322. Iwata S. Study of the effects of environmental factors on the local incidence of amyotrophic lateral sclerosis. Ecotoxicol Environ Saf. 1977 Dec;1(3):297–303. doi: 10.1016/0147-6513(77)90021-5. [DOI] [PubMed] [Google Scholar]
  323. JACOBS P. A., BRUNTON M., COURT BROWN W. M., DOLL R., GOLDSTEIN H. Change of human chromosome count distribution with age: evidence for a sex differences. Nature. 1963 Mar 16;197:1080–1081. doi: 10.1038/1971080a0. [DOI] [PubMed] [Google Scholar]
  324. Jacobs P. A., Mayer M. The origin of human trisomy: a study of heteromorphisms and satellite associations. Ann Hum Genet. 1981 Oct;45(Pt 4):357–365. doi: 10.1111/j.1469-1809.1981.tb00349.x. [DOI] [PubMed] [Google Scholar]
  325. James D. G., Neville E. Pathobiology of sarcoidosis. Pathobiol Annu. 1977;7:31–61. [PubMed] [Google Scholar]
  326. Jarvik L. F., Yen F. S., Fu T. K., Matsuyama S. S. Chromosomes in old age: a six year longitudinal study. Hum Genet. 1976 Jul 7;33(1):17–22. doi: 10.1007/BF00447282. [DOI] [PubMed] [Google Scholar]
  327. Jerzmanowski A., Staron K. Mg3+ as a trigger of condensation-decondensation transition of chromatin during mitosis. J Theor Biol. 1980 Jan 7;82(1):41–46. doi: 10.1016/0022-5193(80)90089-2. [DOI] [PubMed] [Google Scholar]
  328. Jones J. M., Amos H. E. Contact sensitivity in vitro. II. The effect of beryllium preparations on the proliferative responses of specifically allergised lymphocytes and normal lymphocytes stimulated with PHA. Int Arch Allergy Appl Immunol. 1975;48(1):22–29. [PubMed] [Google Scholar]
  329. Jonker C., Eikelenboom P., Tavenier P. Immunological indices in the cerebrospinal fluid of patients with presenile dementia of the Alzheimer type. Br J Psychiatry. 1982 Jan;140:44–49. doi: 10.1192/bjp.140.1.44. [DOI] [PubMed] [Google Scholar]
  330. Julshamn K., Andersen K. J., Willassen Y., Braekkan O. R. A routine method for the determination of aluminium in human tissue samples using standard addition and graphite furnace atomic absorption spectrophotometry. Anal Biochem. 1978 Aug 1;88(2):552–559. doi: 10.1016/0003-2697(78)90455-4. [DOI] [PubMed] [Google Scholar]
  331. KLATZO I., WISNIEWSKI H., STREICHER E. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS. J Neuropathol Exp Neurol. 1965 Apr;24:187–199. doi: 10.1097/00005072-196504000-00002. [DOI] [PubMed] [Google Scholar]
  332. KLEMPERER F. W., MARTIN A. P., LIDDY R. E. The fate of beryllium compounds in the rat. Arch Biochem Biophys. 1952 Nov;41(1):148–152. doi: 10.1016/0003-9861(52)90514-6. [DOI] [PubMed] [Google Scholar]
  333. KOHN R. R., ROLLERSON E. Aging of human collagen in relation to susceptibility to the action of collagenase. J Gerontol. 1960 Jan;15:10–14. doi: 10.1093/geronj/15.1.10. [DOI] [PubMed] [Google Scholar]
  334. KRAINTZ L., TALMAGE R. V. Distribution of radioactivity following intravenous administration of trivalent chromium 51 in the rat and rabbit. Proc Soc Exp Biol Med. 1952 Nov;81(2):490–492. doi: 10.3181/00379727-81-19919. [DOI] [PubMed] [Google Scholar]
  335. Kaehny W. D., Alfrey A. C., Holman R. E., Shorr W. J. Aluminum transfer during hemodialysis. Kidney Int. 1977 Nov;12(5):361–365. doi: 10.1038/ki.1977.123. [DOI] [PubMed] [Google Scholar]
  336. Kaehny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med. 1977 Jun 16;296(24):1389–1390. doi: 10.1056/NEJM197706162962407. [DOI] [PubMed] [Google Scholar]
  337. Kanatsuna T., Freedman Z. R., Rubenstein A. H., Lernmark A. Effects of islet cell surface antibodies and complement on the release of insulin and chromium from perifused beta cells. Clin Exp Immunol. 1982 Jan;47(1):85–92. [PMC free article] [PubMed] [Google Scholar]
  338. Kang K. Y., Bice D., Hoffman E., D'Amato R., Salvaggio J. Experimental studies of sensitization to beryllium, zirconium, and aluminum compounds in the rabbit. J Allergy Clin Immunol. 1977 Jun;59(6):425–436. doi: 10.1016/0091-6749(77)90005-7. [DOI] [PubMed] [Google Scholar]
  339. Kang K. Y., Bice D., Salvaggio J. Delayed hypersensitivity study on zirconium compounds and beryllium sulfate. Med J Osaka Univ. 1976 Mar;26(3-4):131–145. [PubMed] [Google Scholar]
  340. Kanis J. A. Osteomalacia and chronic renal failure. J Clin Pathol. 1981 Nov;34(11):1295–1307. doi: 10.1136/jcp.34.11.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  341. Karlik S. J., Eichhorn G. L., Lewis P. N., Crapper D. R. Interaction of aluminum species with deoxyribonucleic acid. Biochemistry. 1980 Dec 23;19(26):5991–5998. doi: 10.1021/bi00567a008. [DOI] [PubMed] [Google Scholar]
  342. Katzman R. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol. 1976 Apr;33(4):217–218. doi: 10.1001/archneur.1976.00500040001001. [DOI] [PubMed] [Google Scholar]
  343. Kawamura Y., Dyck P. J., Shimono M., Okazaki H., Tateishi J., Doi H. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1981 Nov;40(6):667–675. doi: 10.1097/00005072-198111000-00008. [DOI] [PubMed] [Google Scholar]
  344. Kayne F. J., Komar G., Laboda H., Vanderlinde R. E. Atomic absorption spectrophotometry of chromium in serum and urine with a modified Perkin-Elmer 603 atomic absorption spectrophotometer. Clin Chem. 1978 Dec;24(12):2151–2154. [PubMed] [Google Scholar]
  345. Kent S. Is diabetes a form of accelerated aging? Geriatrics. 1976 Nov;31(11):140, 145, 149-51. [PubMed] [Google Scholar]
  346. Kessler I. I. Epidemiologic studies of Parkinson's disease. 3. A community-based survey. Am J Epidemiol. 1972 Oct;96(4):242–254. doi: 10.1093/oxfordjournals.aje.a121455. [DOI] [PubMed] [Google Scholar]
  347. Kessler I. I. Epidemiologic studies of Parkinson's disease. II. A hospital-based survey. Am J Epidemiol. 1972 Apr;95(4):308–318. doi: 10.1093/oxfordjournals.aje.a121399. [DOI] [PubMed] [Google Scholar]
  348. Kessler I. I. Parkinson's disease in epidemiologic perspective. Adv Neurol. 1978;19:355–384. [PubMed] [Google Scholar]
  349. Kiloh L. G., Lethlean A. K., Morgan G., Cawte J. E., Harris M. An endemic neurological disorder in tribal Australian aborigines. J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):661–668. doi: 10.1136/jnnp.43.8.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  350. King G. A., De Boni U., Crapper D. R. Effect of aluminum upon conditioned avoidance response acquisition in the absence of neurofibrillary degeneration. Pharmacol Biochem Behav. 1975 Nov-Dec;3(6):1003–1009. doi: 10.1016/0091-3057(75)90008-8. [DOI] [PubMed] [Google Scholar]
  351. King S. W., Wills M. R., Savory J. Serum binding of aluminum. Res Commun Chem Pathol Pharmacol. 1979 Oct;26(1):161–169. [PubMed] [Google Scholar]
  352. Kinoshita H., Kumaki K., Nakano H., Tsuyama K., Nagashima R., Okada M., McGraw B. Plasma Aluminum levels of patients on long term sucralfate therapy. Res Commun Chem Pathol Pharmacol. 1982 Mar;35(3):515–518. [PubMed] [Google Scholar]
  353. Klein G. The role of gene dosage and genetic transpositions in carcinogenesis. Nature. 1981 Nov 26;294(5839):313–318. doi: 10.1038/294313a0. [DOI] [PubMed] [Google Scholar]
  354. Koerner D. R. Abnormal carbohydrate metabolism in amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam. Diabetes. 1976 Nov;25(11):1055–1065. doi: 10.2337/diab.25.11.1055. [DOI] [PubMed] [Google Scholar]
  355. Kondo K. Does gastrectomy predispose to amyotrophic lateral sclerosis? Arch Neurol. 1979 Sep;36(9):586–587. doi: 10.1001/archneur.1979.00500450080018. [DOI] [PubMed] [Google Scholar]
  356. Kondo K. Motor neuron disease: changing population patterns and clues for etiology. Adv Neurol. 1978;19:509–543. [PubMed] [Google Scholar]
  357. Kostyniak P. J. An electrothermal atomic absorption method for aluminum analysis in plasma: identification of sources of contamination in blood sampling procedures. J Anal Toxicol. 1983 Jan-Feb;7(1):20–23. doi: 10.1093/jat/7.1.20. [DOI] [PubMed] [Google Scholar]
  358. Kovalchik M. T., Kaehny W. D., Hegg A. P., Jackson J. T., Alfrey A. C. Aluminum kinetics during hemodialysis. J Lab Clin Med. 1978 Nov;92(5):712–720. [PubMed] [Google Scholar]
  359. Krakoff I. H., Newman R. A., Goldberg R. S. Clinical toxicologic and pharmacologic studies of gallium nitrate. Cancer. 1979 Nov;44(5):1722–1727. doi: 10.1002/1097-0142(197911)44:5<1722::aid-cncr2820440528>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  360. Krueger G. L., Morris T. K., Suskind R. R., Widner E. M. The health effects of aluminum compounds in mammals. Crit Rev Toxicol. 1984;13(1):1–24. doi: 10.3109/10408448409029320. [DOI] [PubMed] [Google Scholar]
  361. Kuberski T. T., Bennett P. H. Diabetes mellitus as an emerging public health problem on Guam. Diabetes Care. 1980 Mar-Apr;3(2):235–241. doi: 10.2337/diacare.3.2.235. [DOI] [PubMed] [Google Scholar]
  362. Kuhnert P. M., Kuhnert B. R., Stokes R. M. The effect of in vivo chromium exposure on Na/K-and Mg-ATPase activity in several tissues of the rainbow trout (Salmo gairdneri). Bull Environ Contam Toxicol. 1976 Apr;15(4):383–390. doi: 10.1007/BF01685059. [DOI] [PubMed] [Google Scholar]
  363. Kulprathipanja S., Hnatowich D. J., Beh R., Elmaleh D. Formation constants of gallium- and indium-transferrin. Int J Nucl Med Biol. 1979;6(2):138–141. doi: 10.1016/0047-0740(79)90013-5. [DOI] [PubMed] [Google Scholar]
  364. Kurlander H. M., Patten B. M. Metals in spinal cord tissue of patients dying of motor neuron disease. Ann Neurol. 1979 Jul;6(1):21–24. doi: 10.1002/ana.410060105. [DOI] [PubMed] [Google Scholar]
  365. Kuroiwa Y., Sugita H., Toyokura Y., Mizoguchi M., Matsuo H., Nonaka Y. Immunologic derangement in myotonic dystrophy--abnormal contact sensitization to dinitrochlorobenzene. J Neurol Sci. 1980 Aug;47(2):231–239. doi: 10.1016/0022-510x(80)90007-6. [DOI] [PubMed] [Google Scholar]
  366. Kurtzke J. F., Beebe G. W. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980 May;30(5):453–462. doi: 10.1212/wnl.30.5.453. [DOI] [PubMed] [Google Scholar]
  367. Kuschner M. The carcinogenicity of beryllium. Environ Health Perspect. 1981 Aug;40:101–105. doi: 10.1289/ehp.8140101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  368. Kushelevsky A., Yagil R., Alfasi Z., Berlyne G. M. Uptake of aluminium ion by the liver. Biomedicine. 1976 Apr 20;25(2):59–60. [PubMed] [Google Scholar]
  369. LANGENBECK W., AUGUSTIN M., SCHAEFER C. [On the active metal ions of trypsins]. Hoppe Seylers Z Physiol Chem. 1961 May 30;324:54–57. doi: 10.1515/bchm2.1961.324.1.54. [DOI] [PubMed] [Google Scholar]
  370. Lachine E. E., Noujaim A. A., Ediss C., Wiebe L. I. Toxicity, tissue distribution and excretion of 46ScCl3 and 46Sc-EDTA in mice. Int J Appl Radiat Isot. 1976 Jul;27(7):373–377. doi: 10.1016/0020-708x(76)90091-0. [DOI] [PubMed] [Google Scholar]
  371. Ladurner G., Wawschinek O., Pogglitsch H., Petek W., Urlesberger H., Holzer H. Neurophysiological findings and serum aluminium in dialysis encephalopathy. Eur Neurol. 1982;21(5):335–339. doi: 10.1159/000115500. [DOI] [PubMed] [Google Scholar]
  372. Ladurner G., Wawschinek O., Pogglitsch H., Petek W., Urlesberger H., Holzer H. Neurophysiological findings and serum aluminium in dialysis encephalopathy. Eur Neurol. 1982;21(5):335–339. doi: 10.1159/000115500. [DOI] [PubMed] [Google Scholar]
  373. Lai J. C., Blass J. P. Inhibition of brain glycolysis by aluminum. J Neurochem. 1984 Feb;42(2):438–446. doi: 10.1111/j.1471-4159.1984.tb02697.x. [DOI] [PubMed] [Google Scholar]
  374. Lai J. C., Guest J. F., Leung T. K., Lim L., Davison A. N. The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes. Biochem Pharmacol. 1980 Feb;29(2):141–146. doi: 10.1016/0006-2952(80)90321-4. [DOI] [PubMed] [Google Scholar]
  375. Lai J. C., Lim L., Davison A. N. Effects of Cd2+, Mn2+, and Al3+ on rat brain synaptosomal uptake of noradrenaline and serotonin. J Inorg Biochem. 1982 Nov;17(3):215–225. doi: 10.1016/s0162-0134(00)80100-2. [DOI] [PubMed] [Google Scholar]
  376. Langner P. H., Lang C. M., Singh S. B., Munger B. L., Abt A. B. Glomerular basement membrane changes in aging nondiabetic and diabetic guinea pigs. Exp Aging Res. 1981 Summer;7(2):93–105. doi: 10.1080/03610738108259792. [DOI] [PubMed] [Google Scholar]
  377. Lansdown A. B. Production of epidermal damage in mammalian skins by some simple aluminium compounds. Br J Dermatol. 1973 Jul;89(1):67–76. doi: 10.1111/j.1365-2133.1973.tb01919.x. [DOI] [PubMed] [Google Scholar]
  378. Larson S. M., Grunbaum Z., Rasey J. S. The role of transferrins in gallium uptake. Int J Nucl Med Biol. 1981;8(4):257–266. doi: 10.1016/0047-0740(81)90031-0. [DOI] [PubMed] [Google Scholar]
  379. Larson S. M., Rasey J. S., Allen D. R., Nelson N. J. A transferrin-mediated uptake of gallium-67 by EMT-6 sarcoma. I. Studies in tissue culture. J Nucl Med. 1979 Aug;20(8):837–842. [PubMed] [Google Scholar]
  380. Larson S. M., Rasey J. S., Allen D. R., Nelson N. J., Grunbaum Z., Harp G. D., Williams D. L. Common pathway for tumor cell uptake of gallium-67 and iron-59 via a transferrin receptor. J Natl Cancer Inst. 1980 Jan;64(1):41–53. [PubMed] [Google Scholar]
  381. Larson S. M., Schall G. L. Gallium 67 concentration in human breast milk. JAMA. 1971 Oct 11;218(2):257–257. [PubMed] [Google Scholar]
  382. Leake R. E., Trench M. E., Barry J. M. Effect of cations on the consideration of hen erythrocyte nuclei and its relation to gene activation. Exp Cell Res. 1972 Mar;71(1):17–26. doi: 10.1016/0014-4827(72)90257-1. [DOI] [PubMed] [Google Scholar]
  383. Lederman R. J., Henry C. E. Progressive dialysis encephalopathy. Ann Neurol. 1978 Sep;4(3):199–204. doi: 10.1002/ana.410040302. [DOI] [PubMed] [Google Scholar]
  384. Leininger J. R., Farrell R. L., Johnson G. R. Acute lung lesions due to zirconium and aluminum compounds in hamsters. Arch Pathol Lab Med. 1977 Oct;101(10):545–549. [PubMed] [Google Scholar]
  385. Lepault J., Bram S., Escaig J., Wray W. Chromatin freeze fracture electron microscopy: a comparative study of core particles, chromatin, metaphase chromosomes, and nuclei. Nucleic Acids Res. 1980 Jan 25;8(2):265–278. doi: 10.1093/nar/8.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  386. Leung F. Y., Henderson A. R. Improved determination of aluminum in serum and urine with use of a stabilized temperature platform furnace. Clin Chem. 1982 Oct;28(10):2139–2143. [PubMed] [Google Scholar]
  387. Levin S., Schlesinger M., Handzel Z., Hahn T., Altman Y., Czernobilsky B., Boss J. Thymic deficiency in Down's syndrome. Pediatrics. 1979 Jan;63(1):80–87. [PubMed] [Google Scholar]
  388. Levine R. A., Streeten D. H., Doisy R. J. Effects of oral chromium supplementation on the glucose tolerance of elderly human subjects. Metabolism. 1968 Feb;17(2):114–125. doi: 10.1016/0026-0495(68)90137-6. [DOI] [PubMed] [Google Scholar]
  389. Levis A. G., Bianchi V., Tamino G., Pegoraro B. Cytotoxic effects of hexavalent and trivalent chromium on mammalian cells in vitro. Br J Cancer. 1978 Mar;37(3):386–396. doi: 10.1038/bjc.1978.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  390. Levis A. G., Buttignol M., Bianchi V., Sponza G. Effects of potassium dichromate on nucleic acid and protein syntheses and on precursor uptake in BHK fibroblasts. Cancer Res. 1978 Jan;38(1):110–116. [PubMed] [Google Scholar]
  391. Levis A. G., Majone F. Cytotoxic and clastogenic effects of soluble and insoluble compounds containing hexavalent and trivalent chromium. Br J Cancer. 1981 Aug;44(2):219–235. doi: 10.1038/bjc.1981.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  392. Lewis P. D. Parkinsonism--neuropathology. Br Med J. 1971 Sep 18;3(5776):690–692. doi: 10.1136/bmj.3.5776.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  393. Lewis P. N., Lukiw W. J., De Boni U., McLachlan D. R. Changes in chromatin structure associated with Alzheimer's disease. J Neurochem. 1981 Nov;37(5):1193–1202. doi: 10.1111/j.1471-4159.1981.tb04670.x. [DOI] [PubMed] [Google Scholar]
  394. Lezhava T. A. Geterokhromatinizatsiia--odin iz vedushchikh faktorov stareniia. Tsitol Genet. 1980 May-Jun;14(3):71–76. [PubMed] [Google Scholar]
  395. Lieberherr M., Grosse B., Cournot-Witmer G., Thil C. L., Balsan S. In vitro effects of aluminum on bone phosphatases: a possible interaction with bPTH and vitamin D3 metabolites. Calcif Tissue Int. 1982 May;34(3):280–284. doi: 10.1007/BF02411251. [DOI] [PubMed] [Google Scholar]
  396. Lifschitz M. L., Wallach S., Peabody R. A., Verch R. L., Agrawal R. Radiochromium distribution in thyroid and parathyroid deficiency. Am J Clin Nutr. 1980 Jan;33(1):57–62. doi: 10.1093/ajcn/33.1.57. [DOI] [PubMed] [Google Scholar]
  397. Lim T. H., Sargent T., 3rd, Kusubov N. Kinetics of trace element chromium(III) in the human body. Am J Physiol. 1983 Apr;244(4):R445–R454. doi: 10.1152/ajpregu.1983.244.4.R445. [DOI] [PubMed] [Google Scholar]
  398. Lindvall O., Björklund A., Falck B., Lorén I. Recent developments in aldehyde-induced monoamine fluorescence: the aluminum-formaldehyde (ALFA) method applied to immature and adult central nervous tissue. Histochem J. 1981 Jul;13(4):583–598. doi: 10.1007/BF01002712. [DOI] [PubMed] [Google Scholar]
  399. Lione A. The prophylactic reduction of aluminium intake. Food Chem Toxicol. 1983 Feb;21(1):103–109. doi: 10.1016/0278-6915(83)90277-6. [DOI] [PubMed] [Google Scholar]
  400. Lipman I. J., Boykin M. E., Flora R. E. Glucose intolerance in Parkinson's disease. J Chronic Dis. 1974 Dec;27(11-12):573–579. doi: 10.1016/0021-9681(74)90031-9. [DOI] [PubMed] [Google Scholar]
  401. Liston E. H. The clinical phenomenology of presenile dementia. A critical review of the literature. J Nerv Ment Dis. 1979 Jun;167(6):329–336. doi: 10.1097/00005053-197906000-00001. [DOI] [PubMed] [Google Scholar]
  402. Litvinov N. N., Popov V. A. Ob autoallergicheskoi reaktsii v serdtse éksperimental'nykh zhivotnykh pri deistvii okisi (BeO) i khlorida (BEC12) berilliia. Gig Tr Prof Zabol. 1982 Aug;(8):39–42. [PubMed] [Google Scholar]
  403. Lloyd S. J., Emery A. E. A possible circulating plasma factor in Duchenne muscular dystrophy. Clin Chim Acta. 1981 Apr 27;112(1):85–90. doi: 10.1016/0009-8981(81)90271-0. [DOI] [PubMed] [Google Scholar]
  404. Lotz M., Zisman E., Bartter F. C. Evidence for a phosphorus-depletion syndrome in man. N Engl J Med. 1968 Feb 22;278(8):409–415. doi: 10.1056/NEJM196802222780802. [DOI] [PubMed] [Google Scholar]
  405. Luciani S., Dal Toso R., Rebellato A. M., Levis A. G. Effects of chromium compounds on plasma membrane Mg2+-ATPase activity of BHK cells. Chem Biol Interact. 1979 Sep;27(1):59–67. doi: 10.1016/0009-2797(79)90149-2. [DOI] [PubMed] [Google Scholar]
  406. Luke M. Z., Hamilton L., Hollocher T. C. Beryllium-induced misincorporation by a DNA polymerase: a possible factor in beryllium toxicity. Biochem Biophys Res Commun. 1975 Jan 20;62(2):497–501. doi: 10.1016/s0006-291x(75)80166-5. [DOI] [PubMed] [Google Scholar]
  407. Léonard A., Lauwerys R. R. Carcinogenicity and mutagenicity of chromium. Mutat Res. 1980 Nov;76(3):227–239. doi: 10.1016/0165-1110(80)90018-4. [DOI] [PubMed] [Google Scholar]
  408. MCLAUGHLIN A. I., KAZANTZIS G., KING E., TEARED, PORTER R. J., OWEN R. Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminium dust. Br J Ind Med. 1962 Oct;19:253–263. doi: 10.1136/oem.19.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  409. MERTZ W., ROGINSKI E. E., SCHWARZ K. Effect of trivalent chromium complexes on glucose uptake by epididymal fat tissue of rats. J Biol Chem. 1961 Feb;236:318–322. [PubMed] [Google Scholar]
  410. MERTZ W., ROGINSKI E. E. The effect of trivalent chromium on galactose entry in rat epididymal fat tissue. J Biol Chem. 1963 Mar;238:868–872. [PubMed] [Google Scholar]
  411. Macdonald S. M., Goldstone A. H., Morris J. E., Exton-Smith A. N., Callard R. E. Immunological parameters in the aged and in Alzheimer's disease. Clin Exp Immunol. 1982 Jul;49(1):123–128. [PMC free article] [PubMed] [Google Scholar]
  412. Maceira J. M., Fukuyama K., Epstein W. L., Rowden G. Immunohistochemical demonstration of S-100 protein antigen-containing cells in beryllium-induced, zirconium-induced and sarcoidosis granulomas. Am J Clin Pathol. 1984 May;81(5):563–568. doi: 10.1093/ajcp/81.5.563. [DOI] [PubMed] [Google Scholar]
  413. Macneal R. K., Purich D. L. Chromium (III)-nucleotide complexes as probes of the guanosine 5'-triphosphate-induced microtubule assembly. Arch Biochem Biophys. 1978 Nov;191(1):233–243. doi: 10.1016/0003-9861(78)90086-3. [DOI] [PubMed] [Google Scholar]
  414. Maguire M. E. Magnesium regulation of the beta-receptor-adenylate cyclase complex. II. Sc3+ as a Mg2 antagonist. Mol Pharmacol. 1982 Sep;22(2):274–280. [PubMed] [Google Scholar]
  415. Mahon D. F., Subramaniam G., McAfee J. G. Experimental comparison of radioactive agents for studies of the placenta. J Nucl Med. 1973 Sep;14(9):651–659. [PubMed] [Google Scholar]
  416. Mahurkar S. D., Salta R., Smith E. C., Dhar S. K., Meyers L., Jr, Dunea G. Dialysis dementia. Lancet. 1973 Jun 23;1(7817):1412–1415. doi: 10.1016/s0140-6736(73)91740-6. [DOI] [PubMed] [Google Scholar]
  417. Makinodan T., Kay M. M. Age influence on the immune system. Adv Immunol. 1980;29:287–330. doi: 10.1016/s0065-2776(08)60047-4. [DOI] [PubMed] [Google Scholar]
  418. Mallette L. E., Patten B. M., Engel W. K. Neuromuscular disease in secondary hyperparathyroidism. Ann Intern Med. 1975 Apr;82(4):474–483. doi: 10.7326/0003-4819-82-4-474. [DOI] [PubMed] [Google Scholar]
  419. Mallette L. E., Patten B., Cook J. D., Engel W. K. Calcium metabolism in amyotrophic lateral sclerosis. Dis Nerv Syst. 1977 Jun;38(6):457–461. [PubMed] [Google Scholar]
  420. Maloney N. A., Ott S. M., Alfrey A. C., Miller N. L., Coburn J. W., Sherrard D. J. Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med. 1982 Feb;99(2):206–216. [PubMed] [Google Scholar]
  421. Mancardi G. L., Perdelli F., Rivano C., Leonardi A., Bugiani O. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol. 1980;49(1):79–83. doi: 10.1007/BF00692225. [DOI] [PubMed] [Google Scholar]
  422. Manfredi O. L., Weiss L. E. Gallium-67 citrate in human tumors. Ultrastructural localization by autoradiography. N Y State J Med. 1978 May;78(6):884–887. [PubMed] [Google Scholar]
  423. Mann D. M., Neary D., Yates P. O., Lincoln J., Snowden J. S., Stanworth P. Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1981 Feb;44(2):97–102. doi: 10.1136/jnnp.44.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  424. Mann D. M., Neary D., Yates P. O., Lincoln J., Snowden J. S., Stanworth P. Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease. Neuropathol Appl Neurobiol. 1981 Jan-Feb;7(1):37–47. doi: 10.1111/j.1365-2990.1981.tb00230.x. [DOI] [PubMed] [Google Scholar]
  425. Mann D. M. Nerve cell protein metabolism and degenerative disease. Neuropathol Appl Neurobiol. 1982 May-Jun;8(3):161–176. doi: 10.1111/j.1365-2990.1982.tb00272.x. [DOI] [PubMed] [Google Scholar]
  426. Mann D. M., Yates P. O., Barton C. M. Cytophotometric mapping of neuronal changes in senile dementia. J Neurol Neurosurg Psychiatry. 1977 Mar;40(3):299–302. doi: 10.1136/jnnp.40.3.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  427. Mann D. M., Yates P. O., Marcyniuk B. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Dev. 1984 Apr-May;25(1-2):189–204. doi: 10.1016/0047-6374(84)90140-4. [DOI] [PubMed] [Google Scholar]
  428. Mann D. M., Yates P. O. Pathogenesis of Parkinson's disease. Arch Neurol. 1982 Sep;39(9):545–549. doi: 10.1001/archneur.1982.00510210015004. [DOI] [PubMed] [Google Scholar]
  429. Mann D. M., Yates P. O. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech Ageing Dev. 1983 Feb;21(2):193–203. doi: 10.1016/0047-6374(83)90074-x. [DOI] [PubMed] [Google Scholar]
  430. Mann D. M., Yates P. O. The relationship between formation of senile plaques and neurofibrillary tangles and changes in nerve cell metabolism in Alzheimer type dementia. Mech Ageing Dev. 1981 Dec;17(4):395–401. doi: 10.1016/0047-6374(81)90056-7. [DOI] [PubMed] [Google Scholar]
  431. Mansour J. M., Ehrlich A., Mansour T. E. The dual effects of aluminum as activator and inhibitor of adenylate cyclase in the liver fluke Fasciola hepatica. Biochem Biophys Res Commun. 1983 May 16;112(3):911–918. doi: 10.1016/0006-291x(83)91704-7. [DOI] [PubMed] [Google Scholar]
  432. Markesbery W. R., Ehmann W. D., Hossain T. I., Alauddin M., Goodin D. T. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann Neurol. 1981 Dec;10(6):511–516. doi: 10.1002/ana.410100604. [DOI] [PubMed] [Google Scholar]
  433. Marquis J. K. Aluminum inhibition of human serum cholinesterase. Bull Environ Contam Toxicol. 1983 Aug;31(2):164–169. doi: 10.1007/BF01607888. [DOI] [PubMed] [Google Scholar]
  434. Marquis J. K., Lerrick A. J. Noncompetitive inhibition by aluminum, scandium and yttrium of acetylcholinesterase from Electrophorus electricus. Biochem Pharmacol. 1982 Apr 1;31(7):1437–1440. doi: 10.1016/0006-2952(82)90040-5. [DOI] [PubMed] [Google Scholar]
  435. Marsden S. N., Parkinson I. S., Ward M. K., Ellis H. A., Kerr D. N. Evidence for aluminium accumulation in renal failure. Proc Eur Dial Transplant Assoc. 1979;16:588–596. [PubMed] [Google Scholar]
  436. Martin J. M., Kellett J. M., Kahn J. Aneuploidy in cultured human lymphocytes: I. Age and sex differences. Age Ageing. 1980 Aug;9(3):147–153. doi: 10.1093/ageing/9.3.147. [DOI] [PubMed] [Google Scholar]
  437. Martin J. M., Kellett J. M., Kahn J. Aneuploidy in cultured human lymphocytes: II. A comparison between senescence and dementia. Age Ageing. 1981 Feb;10(1):24–28. doi: 10.1093/ageing/10.1.24. [DOI] [PubMed] [Google Scholar]
  438. Marttila R. J., Eskola J., Päivärinta M., Rinne U. K. Immune functions in Parkinson's disease. Adv Neurol. 1984;40:315–323. [PubMed] [Google Scholar]
  439. Marttila R. J., Rinne U. K. Dementia in Parkinson's disease. Acta Neurol Scand. 1976 Nov;54(5):431–441. doi: 10.1111/j.1600-0404.1976.tb04375.x. [DOI] [PubMed] [Google Scholar]
  440. Marttila R. J., Rinne U. K. Epidemiology of Parkinson's disease--an overview. J Neural Transm. 1981;51(1-2):135–148. doi: 10.1007/BF01664011. [DOI] [PubMed] [Google Scholar]
  441. Mason L., Weinkove C. Radioenzymatic assay of catecholamines: reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine. Ann Clin Biochem. 1983 Mar;20(Pt 2):105–111. doi: 10.1177/000456328302000209. [DOI] [PubMed] [Google Scholar]
  442. Masters C. L. Etiology and pathogenesis of Alzheimer's disease. Pathology. 1984 Jul;16(3):233–234. doi: 10.3109/00313028409068528. [DOI] [PubMed] [Google Scholar]
  443. Masters C. L., Gajdusek D. C., Gibbs C. J., Jr The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain. 1981 Sep;104(3):535–558. doi: 10.1093/brain/104.3.535. [DOI] [PubMed] [Google Scholar]
  444. Maunder-Sewry C. A., Dubowitz V. Myonuclear calcium in carriers of Duchenne muscular dystrophy. An X-ray microanalysis study. J Neurol Sci. 1979 Aug;42(3):337–347. doi: 10.1016/0022-510x(79)90167-9. [DOI] [PubMed] [Google Scholar]
  445. Maunder-Sewry C. A., Gorodetsky R., Yarom R., Dubowitz V. Element analysis of skeletal muscle in Duchenne muscular dystrophy using x-ray fluorescence spectrometry. Muscle Nerve. 1980 Nov-Dec;3(6):502–508. doi: 10.1002/mus.880030607. [DOI] [PubMed] [Google Scholar]
  446. Maunder C. A., Yarom R., Dubowitz V. Electron-microscopic X-ray microanalysis of normal and diseased human muscle. J Neurol Sci. 1977 Sep;33(3):323–334. doi: 10.1016/0022-510x(77)90129-0. [DOI] [PubMed] [Google Scholar]
  447. Mayeux R., Stern Y. Intellectual dysfunction and dementia in Parkinson disease. Adv Neurol. 1983;38:211–227. [PubMed] [Google Scholar]
  448. Mayor G. H., Keiser J. A., Makdani D., Ku P. K. Aluminum absorption and distribution: effect of parathyroid hormone. Science. 1977 Sep 16;197(4309):1187–1189. doi: 10.1126/science.897661. [DOI] [PubMed] [Google Scholar]
  449. Mayor G. H., Sprague S. M., Hourani M. R., Sanchez T. V. Parathyroid hormone-mediated aluminum deposition and egress in the rat. Kidney Int. 1980 Jan;17(1):40–44. doi: 10.1038/ki.1980.5. [DOI] [PubMed] [Google Scholar]
  450. Mazarguil H., Haran R., Laussac J. P. The binding of aluminium to [Leu5]-enkephalin. An investigation using 1H, 13C and 27Al NMR spectroscopy. Biochim Biophys Acta. 1982 Aug 27;717(3):465–472. doi: 10.1016/0304-4165(82)90289-6. [DOI] [PubMed] [Google Scholar]
  451. McDermott J. R., Smith A. I., Iqbal K., Wisniewski H. M. Brain aluminum in aging and Alzheimer disease. Neurology. 1979 Jun;29(6):809–814. doi: 10.1212/wnl.29.6.809. [DOI] [PubMed] [Google Scholar]
  452. McDermott J. R., Smith A. I., Ward M. K., Parkinson I. S., Kerr D. N. Brain-aluminium concentration in dialysis encephalopathy. Lancet. 1978 Apr 29;1(8070):901–904. doi: 10.1016/s0140-6736(78)90681-5. [DOI] [PubMed] [Google Scholar]
  453. McGeer P. L., McGeer E. G., Suzuki J., Dolman C. E., Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology. 1984 Jun;34(6):741–745. doi: 10.1212/wnl.34.6.741. [DOI] [PubMed] [Google Scholar]
  454. McIntyre P. A., Larson S. M., Eikman E. A., Colman M., Scheffel U., Hodkinson B. A. Comparison of the metabolism of iron-labeled transferrin (Fe-TF) and indium-labeled transferrin (In-TF) by the erythropoietic marrow. J Nucl Med. 1974 Oct;15(10):856–862. [PubMed] [Google Scholar]
  455. McKinney T. D., Basinger M., Dawson E., Jones M. M. Serum aluminum levels in dialysis dementia. Nephron. 1982;32(1):53–56. doi: 10.1159/000182802. [DOI] [PubMed] [Google Scholar]
  456. McMartin D. N., Schedlbauer L. M. Effect of experimental colchicine encephalopathy on brain protein synthesis and tubulin metabolism. J Neurobiol. 1978 Nov;9(6):453–463. doi: 10.1002/neu.480090605. [DOI] [PubMed] [Google Scholar]
  457. Medrano E., Piras R., Mordoh J. Effect of colchicine, vinblastine and cytochalasin B on human lymphocyte transformation by phytohemagglutinin. Exp Cell Res. 1974 Jun;86(2):295–300. doi: 10.1016/0014-4827(74)90716-2. [DOI] [PubMed] [Google Scholar]
  458. Mena I., Marin O., Fuenzalida S., Cotzias G. C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology. 1967 Feb;17(2):128–136. doi: 10.1212/wnl.17.2.128. [DOI] [PubMed] [Google Scholar]
  459. Meredith P. A., Moore M. R., Goldberg A. Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme. 1977;22(1):22–27. doi: 10.1159/000458503. [DOI] [PubMed] [Google Scholar]
  460. Mertz W. Chromium occurrence and function in biological systems. Physiol Rev. 1969 Apr;49(2):163–239. doi: 10.1152/physrev.1969.49.2.163. [DOI] [PubMed] [Google Scholar]
  461. Mertz W., Roginski E. E., Reba R. C. Biological activity and fate of trace quantities of intravenous chromium (3) in the rat. Am J Physiol. 1965 Sep;209(3):489–494. doi: 10.1152/ajplegacy.1965.209.3.489. [DOI] [PubMed] [Google Scholar]
  462. Mertz W., Toepfer E. W., Roginski E. E., Polansky M. M. Present knowledge of the role of chromium. Fed Proc. 1974 Nov;33(11):2275–2280. [PubMed] [Google Scholar]
  463. Merz T., Malmud L., McKusick K., Wagner H. N., Jr The mechanism of 67 Ga association with lymphocytes. Cancer Res. 1974 Oct;34(10):2495–2499. [PubMed] [Google Scholar]
  464. Mikkelsen M., Fischer G., Hansen J., Pilgaard B., Nielsen J. The impact of legal termination of pregnancy and of prenatal diagnosis on the birth prevalence of Down syndrome in Denmark. Ann Hum Genet. 1983 May;47(Pt 2):123–131. doi: 10.1111/j.1469-1809.1983.tb00979.x. [DOI] [PubMed] [Google Scholar]
  465. Milder M. S., Cook J. D., Stray S., Finch C. A. Idiopathic hemochromatosis, an interim report. Medicine (Baltimore) 1980 Jan;59(1):34–49. doi: 10.1097/00005792-198001000-00002. [DOI] [PubMed] [Google Scholar]
  466. Miller C. A., Levine E. M. Effects of aluminum salts on cultured neuroblastoma cells. J Neurochem. 1974 May;22(5):751–758. doi: 10.1111/j.1471-4159.1974.tb04290.x. [DOI] [PubMed] [Google Scholar]
  467. Milunsky A. Glucose intolerance in the parents of children with Down's syndrome. Am J Ment Defic. 1970 Jan;74(4):475–478. [PubMed] [Google Scholar]
  468. Milunsky A., Neurath P. W. Diabetes mellitus in Down's Syndrome. Arch Environ Health. 1968 Sep;17(3):372–376. doi: 10.1080/00039896.1968.10665244. [DOI] [PubMed] [Google Scholar]
  469. Miyakawa T., Shimoji A., Kuramoto R., Higuchi Y. The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982 Aug;40(2):121–129. doi: 10.1007/BF02932857. [DOI] [PubMed] [Google Scholar]
  470. Miyakawa T., Uehara Y. Observations of amyloid angiopathy and senile plaques by the scanning electron microscope. Acta Neuropathol. 1979 Nov;48(2):153–156. doi: 10.1007/BF00691158. [DOI] [PubMed] [Google Scholar]
  471. Miyata S., Nakamura S., Toyoshima M., Kameyama M., Koyama M. [The distribution of manganese in the spinal cord of amyotrophic lateral sclerosis -- determination of manganese by neutron activation analysis (author's transl)]. Rinsho Shinkeigaku. 1980 Nov;20(11):917–923. [PubMed] [Google Scholar]
  472. Mizumoto Y., Iwata S., Sasajima K., Yase Y., Yoshida S. [Alpha particle excited X-ray fluorescence analysis for trace elements in cervical spinal cords of amyotrophic lateral sclerosis (author's transl)]. Radioisotopes. 1980 Dec;29(12):585–589. [PubMed] [Google Scholar]
  473. Moerlein S. M., Welch M. J., Raymond K. N., Weitl F. L. Tricatecholamide analogs of enterobactin as gallium- and indium-binding radiopharmaceuticals. J Nucl Med. 1981 Aug;22(8):710–719. [PubMed] [Google Scholar]
  474. Moreau-Dubois M. C., Brown P., Goudsmit J., Cathala F., Gajdusek D. C. Biologic distinction between sporadic and familial Alzheimer disease by an in vitro cell fusion test. Neurology. 1981 Mar;31(3):323–325. doi: 10.1212/wnl.31.3.323. [DOI] [PubMed] [Google Scholar]
  475. Morita K., Inoue S., Murai Y., Watanabe K., Shima S. Effects of the metals, Be, Fe, Cu and Al, on the mobility of immunoglobulin receptors. Experientia. 1982 Oct 15;38(10):1227–1228. doi: 10.1007/BF01959755. [DOI] [PubMed] [Google Scholar]
  476. Morita M., Minowada J., Sandberg A. A. Chromosomes and causation of human cancer and leukemia. XLV. Chromosome patterns in stimulated lymphocytes of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 1981 Jun;3(4):293–306. doi: 10.1016/0165-4608(81)90038-8. [DOI] [PubMed] [Google Scholar]
  477. Morrissey J., Rothstein M., Mayor G., Slatopolsky E. Suppression of parathyroid hormone secretion by aluminum. Kidney Int. 1983 May;23(5):699–704. doi: 10.1038/ki.1983.81. [DOI] [PubMed] [Google Scholar]
  478. Mullen A. L., Stanley R. E., Lloyd S. R., Moghissi A. A. Radioberyllium metabolism by the dairy cow. Health Phys. 1972 Jan;22(1):17–22. doi: 10.1097/00004032-197201000-00003. [DOI] [PubMed] [Google Scholar]
  479. Mussi I., Calzaferri G., Buratti M., Alessio L. Behaviour of plasma and urinary aluminium levels in occupationally exposed subjects. Int Arch Occup Environ Health. 1984;54(2):155–161. doi: 10.1007/BF00378518. [DOI] [PubMed] [Google Scholar]
  480. Mussi I., Calzaferri G., Buratti M., Alessio L. Behaviour of plasma and urinary aluminium levels in occupationally exposed subjects. Int Arch Occup Environ Health. 1984;54(2):155–161. doi: 10.1007/BF00378518. [DOI] [PubMed] [Google Scholar]
  481. Myśliwski A., Myśliwska J., Kmieć Z. Age-related changes in chromatin of liver cell nuclei of different ploidity. Histochemistry. 1977 Apr 20;52(1):91–96. doi: 10.1007/BF00495818. [DOI] [PubMed] [Google Scholar]
  482. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med. 1981 Jan;94(1):73–94. doi: 10.7326/0003-4819-94-1-73. [DOI] [PubMed] [Google Scholar]
  483. Nadel A. M., Wilson W. P. Dialysis encephalopathy: a possible seizure disorder. Neurology. 1976 Dec;26(12):1130–1134. doi: 10.1212/wnl.26.12.1130. [DOI] [PubMed] [Google Scholar]
  484. Naeim F., Walford R. L. Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals. J Gerontol. 1980 Sep;35(5):650–655. doi: 10.1093/geronj/35.5.650. [DOI] [PubMed] [Google Scholar]
  485. Nagano Y., Tsubaki T., Chase T. N. Endocrinologic regulation of carbohydrate metabolism. Amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam. Arch Neurol. 1979 Apr;36(4):217–220. doi: 10.1001/archneur.1979.00500400071011. [DOI] [PubMed] [Google Scholar]
  486. Nagy I. Z., Nagy V. Z. Age-dependence of heat-induced strand separation of DNA in situ in postmitotic cells of rat brain as revealed by acridine orange microfluorimetry. Mech Ageing Dev. 1975 Sep-Dec;4(5-6):349–360. doi: 10.1016/0047-6374(75)90035-4. [DOI] [PubMed] [Google Scholar]
  487. Najfeld V., Fialkow P. J., Karande A., Nilsson K., Klein G., Penfold G. Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia. Int J Cancer. 1980 Nov 15;26(5):543–549. doi: 10.1002/ijc.2910260504. [DOI] [PubMed] [Google Scholar]
  488. Nakamuro K., Yoshikawa K., Sayato Y., Kurata H. Comparative studies of chromosomal aberration and mutagenicity of the trivalent and hexavalent chromium. Mutat Res. 1978 Nov;58(2-3):175–181. doi: 10.1016/0165-1218(78)90007-1. [DOI] [PubMed] [Google Scholar]
  489. Nathan E., Pedersen S. E. Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally. Acta Paediatr Scand. 1980 Nov;69(6):793–796. doi: 10.1111/j.1651-2227.1980.tb07155.x. [DOI] [PubMed] [Google Scholar]
  490. Neet K. E., Furman T. C., Hueston W. J. Activation of yeast hexokinase by chelators and the enzymic slow transition due to metal-nucleotide interactions. Arch Biochem Biophys. 1982 Jan;213(1):14–25. doi: 10.1016/0003-9861(82)90434-9. [DOI] [PubMed] [Google Scholar]
  491. Nelson B., Hayes R. L., Edwards C. L., Kniseley R. M., Andrews G. A. Distribution of gallium in human tissues after intravenous administration. J Nucl Med. 1972 Jan;13(1):92–100. [PubMed] [Google Scholar]
  492. Nemo G. J., Brody J. A., Cruz M. Lymphocyte transformation study of Guamanian patients with amyotrophic lateral sclerosis and Parkinsonism-dementa. Neurology. 1974 Jun;24(6):579–581. doi: 10.1212/wnl.24.6.579. [DOI] [PubMed] [Google Scholar]
  493. Newman R. A., Brody A. R., Krakoff I. H. Gallium nitrate (NSC-15200) induced toxicity in the rat: a pharmacologic, histopathologic and microanalytical investigation. Cancer. 1979 Nov;44(5):1728–1740. doi: 10.1002/1097-0142(197911)44:5<1728::aid-cncr2820440529>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  494. Newman R. A., Gallagher J. G., Clements J. P., Krakoff I. H. Demonstration of Ga-67 localization in human placenta. J Nucl Med. 1978 May;19(5):504–506. [PubMed] [Google Scholar]
  495. Nielsen J. Chromosomes in senile dementia. Br J Psychiatry. 1968 Mar;114(508):303–309. doi: 10.1192/bjp.114.508.303. [DOI] [PubMed] [Google Scholar]
  496. Nielsen J. Diabetes mellitus in patients with aneuploid chromosome aberrations and in their parents. Humangenetik. 1972;16(1):165–170. doi: 10.1007/BF00394004. [DOI] [PubMed] [Google Scholar]
  497. Nielsen T. T. Plasma citrate during submaximal and intermittent supramaximal exercise. Scand J Clin Lab Invest. 1978 Feb;38(1):29–33. doi: 10.3109/00365517809108399. [DOI] [PubMed] [Google Scholar]
  498. Nishida Y., Akaoka I., Suzuki T., Kobayashi M., Maruki K. Serum lymphocytotoxins and lymphocyte responses to mitogens of Down syndrome person. Am J Ment Defic. 1981 May;85(6):596–600. [PubMed] [Google Scholar]
  499. Nishioka H. Mutagenic activities of metal compounds in bacteria. Mutat Res. 1975 Jun;31(3):185–189. doi: 10.1016/0165-1161(75)90088-6. [DOI] [PubMed] [Google Scholar]
  500. Nomiyama H., Yotoriyama M., Nomiyama K. Normal chromium levels in urine and blood of Japanese subjects determined by direct flameless atomic absorption spectrophotometry, and valency of chromium in urine after exposure to hexavalent chromium. Am Ind Hyg Assoc J. 1980 Feb;41(2):98–102. doi: 10.1080/15298668091424438. [DOI] [PubMed] [Google Scholar]
  501. Nordal H. J., Andersson T. R., Dietrichson P. Lymphocyte capping: a diagnostic method in progressive muscular dystrophy? Acta Neurol Scand. 1982 May;65(5):442–447. doi: 10.1111/j.1600-0404.1982.tb03101.x. [DOI] [PubMed] [Google Scholar]
  502. Nordenson I. Population studies in northern Sweden. IX. Incidence of Down's syndrome by time, region and maternal age. Hereditas. 1979;91(2):257–261. doi: 10.1111/j.1601-5223.1979.tb01668.x. [DOI] [PubMed] [Google Scholar]
  503. Norseth T. The carcinogenicity of chromium. Environ Health Perspect. 1981 Aug;40:121–130. doi: 10.1289/ehp.8140121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  504. Noujaim A. A., Lentle B. C., Hill J. R., Terner U. K., Wong H. On the role of transferrin in the uptake of gallium by tumor cells. Int J Nucl Med Biol. 1979;6(4):193–199. doi: 10.1016/0047-0740(79)90038-x. [DOI] [PubMed] [Google Scholar]
  505. Nyholm N. E. Evidence of involvement of aluminum in causation of defective formation of eggshells and of impaired breeding in wild passerine birds. Environ Res. 1981 Dec;26(2):363–371. doi: 10.1016/0013-9351(81)90212-7. [DOI] [PubMed] [Google Scholar]
  506. O'Gara R. W., Brown J. M. Comparison of the carcinogenic actions of subcutaneous implants of iron and aluminum in rodents. J Natl Cancer Inst. 1967 Jun;38(6):947–957. [PubMed] [Google Scholar]
  507. O'Hare J. A., Murnaghan D. J. Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate. N Engl J Med. 1982 Mar 18;306(11):654–656. doi: 10.1056/NEJM198203183061107. [DOI] [PubMed] [Google Scholar]
  508. Ohama E., Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol. 1976 Apr 26;34(4):311–319. doi: 10.1007/BF00696560. [DOI] [PubMed] [Google Scholar]
  509. Ondreicka R., Ginter E., Kortus J. Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism. Br J Ind Med. 1966 Oct;23(4):305–312. doi: 10.1136/oem.23.4.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  510. Onkelinx C. Compartment analysis of metabolism of chromium(III) in rats of various ages. Am J Physiol. 1977 May;232(5):E478–E484. doi: 10.1152/ajpendo.1977.232.5.E478. [DOI] [PubMed] [Google Scholar]
  511. Oster O. The aluminium content of human serum determined by atomic absorption spectroscopy with a graphite furnace. Clin Chim Acta. 1981 Jul 18;114(1):53–60. doi: 10.1016/0009-8981(81)90227-8. [DOI] [PubMed] [Google Scholar]
  512. Osterberg R., Persson D., Bjursell G. The condensation of DNA by chromium (III) ions. J Biomol Struct Dyn. 1984 Oct;2(2):285–290. doi: 10.1080/07391102.1984.10507567. [DOI] [PubMed] [Google Scholar]
  513. Ott S. M. Aluminum - related osteomalacia. Int J Artif Organs. 1983 Jul;6(4):173–175. [PubMed] [Google Scholar]
  514. Ott S. M., Maloney N. A., Coburn J. W., Alfrey A. C., Sherrard D. J. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med. 1982 Sep 16;307(12):709–713. doi: 10.1056/NEJM198209163071202. [DOI] [PubMed] [Google Scholar]
  515. Otten J. A., Tyndall R. L., Estes P. C., Gude W. D., Swartzendruber D. C. Localization of gallium-67 during embryogenesis. Proc Soc Exp Biol Med. 1973 Jan;142(1):92–95. doi: 10.3181/00379727-142-36965. [DOI] [PubMed] [Google Scholar]
  516. Parker V. H., Stevens C. Binding of beryllium to nuclear acidic proteins. Chem Biol Interact. 1979 Jul;26(2):167–177. doi: 10.1016/0009-2797(79)90020-6. [DOI] [PubMed] [Google Scholar]
  517. Parkinson I. S., Ward M. K., Feest T. G., Fawcett R. W., Kerr D. N. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet. 1979 Feb 24;1(8113):406–409. doi: 10.1016/s0140-6736(79)90883-3. [DOI] [PubMed] [Google Scholar]
  518. Parkinson I. S., Ward M. K., Kerr D. N. A method for the routine determination of aluminium in serum and water by flameless atomic absorption spectrometry. Clin Chim Acta. 1982 Oct 27;125(2):125–133. doi: 10.1016/0009-8981(82)90189-9. [DOI] [PubMed] [Google Scholar]
  519. Parkinson I. S., Ward M. K., Kerr D. N. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis. J Clin Pathol. 1981 Nov;34(11):1285–1294. doi: 10.1136/jcp.34.11.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  520. Parsons V., Davies C., Goode C., Ogg C., Siddiqui J. Aluminium in bone from patients with renal failure. Br Med J. 1971 Oct 30;4(5782):273–275. doi: 10.1136/bmj.4.5782.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  521. Patocka J. The influence of A1 +++ on cholinesterase and acetylcholinesterase activity. Acta Biol Med Ger. 1971;26(4):845–846. [PubMed] [Google Scholar]
  522. Patten B. M., Bilezikian J. P., Mallette L. E., Prince A., Engel W. K., Aurbach G. D. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med. 1974 Feb;80(2):182–193. doi: 10.7326/0003-4819-80-2-182. [DOI] [PubMed] [Google Scholar]
  523. Patten B. M., Harati Y., Acosta L., Jung S. S., Felmus M. T. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol. 1978 Apr;3(4):305–309. doi: 10.1002/ana.410030405. [DOI] [PubMed] [Google Scholar]
  524. Pauls H., Bredenbröcker B., Schoner W. Inactivation of (Na+ + K+)-ATPase by chromium(III) complexes of nucleotide triphosphates. Eur J Biochem. 1980 Aug;109(2):523–533. doi: 10.1111/j.1432-1033.1980.tb04824.x. [DOI] [PubMed] [Google Scholar]
  525. Pearce J. The extrapyramidal disorder of Alzheimer's disease. Eur Neurol. 1974;12(2):94–103. doi: 10.1159/000114608. [DOI] [PubMed] [Google Scholar]
  526. Pearson J. D. Use of Cr51-labelled haemoglobin and Sc47 as inert faecal markers. Int J Appl Radiat Isot. 1966 Jan;17(1):13–16. doi: 10.1016/0020-708x(66)90099-8. [DOI] [PubMed] [Google Scholar]
  527. Perl D. P., Brody A. R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980 Apr 18;208(4441):297–299. doi: 10.1126/science.7367858. [DOI] [PubMed] [Google Scholar]
  528. Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., Gibbs C. J. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science. 1982 Sep 10;217(4564):1053–1055. doi: 10.1126/science.7112111. [DOI] [PubMed] [Google Scholar]
  529. Perry H. M., Jr, Perry E. F., Hixon B. B. Trace-metal concentrations in normal human liver: methods to cope with marked variability. Sci Total Environ. 1978 Mar;9(2):125–134. doi: 10.1016/0048-9697(78)90071-2. [DOI] [PubMed] [Google Scholar]
  530. Perry S. T., Kulkarni S. B., Lee K. L., Kenney F. T. Selective effect of the metallocarcinogen beryllium on hormonal regulation of gene expression in cultured cells. Cancer Res. 1982 Feb;42(2):473–476. [PubMed] [Google Scholar]
  531. Petit T. L., Biederman G. B., McMullen P. A. Neurofibrillary degeneration, dendritic dying back, and learning-memory deficits after aluminum administration: implications for brain aging. Exp Neurol. 1980 Jan;67(1):152–162. doi: 10.1016/0014-4886(80)90166-1. [DOI] [PubMed] [Google Scholar]
  532. Petrilli F. L., De Flora S. Interpretations on chromium mutagenicity and carcinogenicity. Prog Clin Biol Res. 1982;109:453–464. [PubMed] [Google Scholar]
  533. Pickard N. A., Gruemer H. D., Verrill H. L., Isaacs E. R., Robinow M., Nance W. E., Myers E. C., Goldsmith B. Systemic membrane defect in the proximal muscular dystrophies. N Engl J Med. 1978 Oct 19;299(16):841–846. doi: 10.1056/NEJM197810192991601. [DOI] [PubMed] [Google Scholar]
  534. Pierides A. M., Edwards W. G., Jr, Cullum U. X., Jr, McCall J. T., Ellis H. A. Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int. 1980 Jul;18(1):115–124. doi: 10.1038/ki.1980.117. [DOI] [PubMed] [Google Scholar]
  535. Pierides A. M., Skillen A. W., Ellis H. A. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3. J Lab Clin Med. 1979 Jun;93(6):899–909. [PubMed] [Google Scholar]
  536. Pillion G., Loirat C., Blum C., Poisson M., Bacri J. L., Broyer M., Mathieu H. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure. Int J Pediatr Nephrol. 1981 Mar;2(1):29–32. [PubMed] [Google Scholar]
  537. Platts M. M., Goode G. C., Hislop J. S. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J. 1977 Sep 10;2(6088):657–660. doi: 10.1136/bmj.2.6088.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  538. Plum F. Dementia: an approaching epidemic. Nature. 1979 May 31;279(5712):372–373. doi: 10.1038/279372a0. [DOI] [PubMed] [Google Scholar]
  539. Polak L., Turk J. L., Frey J. R. Studies on contact hypersensitivity to chromium compounds. Prog Allergy. 1973;17:145–226. [PubMed] [Google Scholar]
  540. Polychronakos C., Letarte J., Collu R., Ducharme J. R. Carbohydrate intolerance in children and adolescents with Turner syndrome. J Pediatr. 1980 Jun;96(6):1009–1014. doi: 10.1016/s0022-3476(80)80627-5. [DOI] [PubMed] [Google Scholar]
  541. Prior J. C., Cameron E. C., Knickerbocker W. J., Sweeney V. P., Suchowersky O. Dialysis encephalopathy and osteomalacic bone disease: a case-controlled study. Am J Med. 1982 Jan;72(1):33–42. doi: 10.1016/0002-9343(82)90574-5. [DOI] [PubMed] [Google Scholar]
  542. RAPOPORT S. Uber die Wirkung von Al und Ca auf das Succinatoxydase-System des Herzmuskels. Hoppe Seylers Z Physiol Chem. 1955 Dec 22;302(4-6):156–160. [PubMed] [Google Scholar]
  543. RAYNER B., TUTT M., VAUGHAN J. The deposition of 91Y in rabbit bones. Br J Exp Pathol. 1953 Apr;34(2):138–145. [PMC free article] [PubMed] [Google Scholar]
  544. REEVES A. L., VORWALD A. J. The humoral transport of beryllium. J Occup Med. 1961 Dec;3:567–574. [PubMed] [Google Scholar]
  545. ROSOFF B., SIEGEL E., WILLIAMS G. L., SPENCER H. Distribution and excretion of radioactive rare-earth compounds in mice. Int J Appl Radiat Isot. 1963 Mar;14:129–135. doi: 10.1016/0020-708x(63)90107-8. [DOI] [PubMed] [Google Scholar]
  546. ROSOFF B., SPENCER H., COHN S. H., GUSMANO E. A. METABOLISM OF SCANDIUM-46 IN MAN. Int J Appl Radiat Isot. 1965 Aug;16:479–485. doi: 10.1016/0020-708x(65)90006-2. [DOI] [PubMed] [Google Scholar]
  547. Rabinowitz M. B., Levin S. R., Gonick H. C. Comparisons of chromium status in diabetic and normal men. Metabolism. 1980 Apr;29(4):355–364. doi: 10.1016/0026-0495(80)90010-4. [DOI] [PubMed] [Google Scholar]
  548. Rajput A. H., Rozdilsky B. Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1092–1100. doi: 10.1136/jnnp.39.11.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  549. Ramel C., Magnusson J. Chemical induction of nondisjunction in drosophila. Environ Health Perspect. 1979 Aug;31:59–66. doi: 10.1289/ehp.793159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  550. Randall M. E. Aluminium toxicity in an infant not on dialysis. Lancet. 1983 Jun 11;1(8337):1327–1328. doi: 10.1016/s0140-6736(83)92433-9. [DOI] [PubMed] [Google Scholar]
  551. Rasey J. S., Nelson N. J., Larson S. M. Relationship of iron metabolism to tumor cell toxicity of stable gallium salts. Int J Nucl Med Biol. 1981;8(4):303–313. doi: 10.1016/0047-0740(81)90037-1. [DOI] [PubMed] [Google Scholar]
  552. Rasool C. G., Abraham C., Anderton B. H., Haugh M., Kahn J., Selkoe D. J. Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies. Brain Res. 1984 Sep 24;310(2):249–260. doi: 10.1016/0006-8993(84)90148-3. [DOI] [PubMed] [Google Scholar]
  553. Read S. G. The distribution of Down's syndrome. J Ment Defic Res. 1982 Dec;26(Pt 4):215–227. doi: 10.1111/j.1365-2788.1982.tb00148.x. [DOI] [PubMed] [Google Scholar]
  554. Recker R. R., Blotcky A. J., Leffler J. A., Rack E. P. Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med. 1977 Nov;90(5):810–815. [PubMed] [Google Scholar]
  555. Reed D. M., Brody J. A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. I. Descriptive epidemiology. Am J Epidemiol. 1975 Apr;101(4):287–301. doi: 10.1093/oxfordjournals.aje.a112097. [DOI] [PubMed] [Google Scholar]
  556. Reed D. M., Torres J. M., Brody J. A. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam, 1945-1972. II. Familial and genetic studies. Am J Epidemiol. 1975 Apr;101(4):302–310. doi: 10.1093/oxfordjournals.aje.a112098. [DOI] [PubMed] [Google Scholar]
  557. Reed D., Plato C., Elizan T., Kurland L. T. The amyotrophic lateral sclerosis/parkinsonism-dementia complex: a ten-year follow-up on Guam. I. Epidemiologic studies. Am J Epidemiol. 1966 Jan;83(1):54–73. doi: 10.1093/oxfordjournals.aje.a120570. [DOI] [PubMed] [Google Scholar]
  558. Reeves A. L. Berylliosis as an auto-immune disorder. Ann Clin Lab Sci. 1976 May-Jun;6(3):256–262. [PubMed] [Google Scholar]
  559. Reeves A. L. Beryllium carcinogenesis. Adv Exp Med Biol. 1977;91:13–27. doi: 10.1007/978-1-4684-0796-9_2. [DOI] [PubMed] [Google Scholar]
  560. Reeves A. L. The absorption of beryllium from the gastrointestinal tract. Arch Environ Health. 1965 Aug;11(2):209–214. doi: 10.1080/00039896.1965.10664200. [DOI] [PubMed] [Google Scholar]
  561. Rej R., Bretaudiere J. P. Effects of metal ions on the measurement of alkaline phosphatase activity. Clin Chem. 1980 Mar;26(3):423–428. [PubMed] [Google Scholar]
  562. Reyes E. T., Perurena O. H., Festoff B. W., Jorgensen R., Moore W. V. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci. 1984 Mar;63(3):317–324. doi: 10.1016/0022-510x(84)90154-0. [DOI] [PubMed] [Google Scholar]
  563. Ris H., Kubai D. F. Chromosome structure. Annu Rev Genet. 1970;4:263–294. doi: 10.1146/annurev.ge.04.120170.001403. [DOI] [PubMed] [Google Scholar]
  564. Robertson J. A., Felsenfeld A. J., Haygood C. C., Wilson P., Clarke C., Llach F. Animal model of aluminum-induced osteomalacia: role of chronic renal failure. Kidney Int. 1983 Feb;23(2):327–335. doi: 10.1038/ki.1983.23. [DOI] [PubMed] [Google Scholar]
  565. Ronai P. High resolution autoradiography with 51Cr. Int J Appl Radiat Isot. 1969 Jun;20(6):471–473. doi: 10.1016/0020-708x(69)90139-2. [DOI] [PubMed] [Google Scholar]
  566. Rose N. R., Kite J. H., Jr, Doebbler T. K., Spier R., Skelton F. R., Witebsky E. Studies on experimental thyroiditis. Ann N Y Acad Sci. 1965 Jun 30;124(1):201–230. doi: 10.1111/j.1749-6632.1965.tb18957.x. [DOI] [PubMed] [Google Scholar]
  567. Roshchin A. V., Taranenko L. A., Muratova N. Z. Sensibiliziruiushchie svoistva metallov indiia, palladiia i vanadiia. Gig Tr Prof Zabol. 1982 Feb;(2):5–8. [PubMed] [Google Scholar]
  568. Rosoff B., Spencer H. Binding of rare earths to serum proteins and DNA. Clin Chim Acta. 1979 May 2;93(3):311–319. doi: 10.1016/0009-8981(79)90280-8. [DOI] [PubMed] [Google Scholar]
  569. Rossor M. N. Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. Br Med J (Clin Res Ed) 1981 Dec 12;283(6306):1588–1590. doi: 10.1136/bmj.283.6306.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  570. Rottembourg J., Gallego J. L., Jaudon M. C., Clavel J. P., Legrain M. Serum concentration and peritoneal transfer of aluminum during treatment by continuous ambulatory peritoneal dialysis. Kidney Int. 1984 Jun;25(6):919–924. doi: 10.1038/ki.1984.110. [DOI] [PubMed] [Google Scholar]
  571. Routh M. W. Analytical parameters for determination of chromium in urine by electrothermal atomic absorption spectrometry. Anal Chem. 1980 Jan;52(1):182–185. doi: 10.1021/ac50051a041. [DOI] [PubMed] [Google Scholar]
  572. Rozas V. V., Port F. K., Rutt W. M. Progressive dialysis encephalopathy from dialysate aluminum. Arch Intern Med. 1978 Sep;138(9):1375–1377. [PubMed] [Google Scholar]
  573. Röthig W., Wehran H. J. Zur Bestimmung von Eisen, Aluminium und Titan in Silikose- und Silikotuberkuloselungen. Dtsch Gesundheitsw. 1972 Aug 17;27(33):1555–1559. [PubMed] [Google Scholar]
  574. SCHROEDER H. A., BALASSA J. J., TIPTON I. H. Abnormal trace metals in man--chromium. J Chronic Dis. 1962 Oct;15:941–964. doi: 10.1016/0021-9681(62)90114-5. [DOI] [PubMed] [Google Scholar]
  575. SCHUBERT J., WHITE M. R. Effect of citrate salts and other chemical factors on the distribution and excretion of beryllium. J Lab Clin Med. 1950 Jun;35(6):854–864. [PubMed] [Google Scholar]
  576. SCHWARZ K., MERTZ W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys. 1959 Nov;85:292–295. doi: 10.1016/0003-9861(59)90479-5. [DOI] [PubMed] [Google Scholar]
  577. SEIBOLD M. [Determination of aluminum in the blood serum with ion exchange resins and eriochrome cyanine-R]. Klin Wochenschr. 1960 Feb 1;38:117–119. doi: 10.1007/BF02189075. [DOI] [PubMed] [Google Scholar]
  578. SHELLEY W. B., HURLEY H. J., MAYOCK R. L., CLOSE H. P., CATHCART R. T. Intradermal tests with metals and other inorganic elements in sarcoidosis and anthraco-silicosis. J Invest Dermatol. 1958 Dec;31(6):301–303. [PubMed] [Google Scholar]
  579. SHELLEY W. B., HURLEY H. J. The allergic origin of zirconium deodorant granulomas. Br J Dermatol. 1958 Mar;70(3):75–101. doi: 10.1111/j.1365-2133.1958.tb13297.x. [DOI] [PubMed] [Google Scholar]
  580. STACY B. D., KING E. J., HARRISON C. V., NAGELSCHMIDT G., NELSON S. Tissue changes in rats' lungs caused by hydroxides, oxides and phosphates of aluminium and iron. J Pathol Bacteriol. 1959 Apr;77(2):417–426. doi: 10.1002/path.1700770212. [DOI] [PubMed] [Google Scholar]
  581. STERNER J. H., EISENBUD M. Epidemiology of beryllium intoxication. AMA Arch Ind Hyg Occup Med. 1951 Aug;4(2):123–151. [PubMed] [Google Scholar]
  582. STITCH S. R. Trace elements in human tissue. 1. A semi-quantitative spectrographic survey. Biochem J. 1957 Sep;67(1):97–103. doi: 10.1042/bj0670097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  583. STRANG R. R. THE ASSOCIATION OF GASTRO-DUODENAL ULCERATION AND PARKINSON'S DISEASE. Med J Aust. 1965 Jun 5;1(23):842–843. doi: 10.5694/j.1326-5377.1965.tb72277.x. [DOI] [PubMed] [Google Scholar]
  584. Sabouraud O., Chatel M., Menault F., Dien Peron J., Cartier F., Garre M., Gary J., Pecker S. L'encéphalopathie myoclonique progressive des dialysés (E.M.P.D.). Etude clinique, électroencéphalographique et neuropathologique. Discussion pathogénique. Rev Neurol (Paris) 1978 Oct;134(10):575–600. [PubMed] [Google Scholar]
  585. Saddi R., Feingold J., Fagard R., Eschwege E. Idiopathic haemochromatosis diabetes: assessment of serum iron and transferin saturation in high and low risk populations for diabetes mellitus. Monogr Hum Genet. 1978;9:20–24. doi: 10.1159/000401605. [DOI] [PubMed] [Google Scholar]
  586. Saddi R., Feingold J. Idiopathic haemochromatosis and diabetes mellitus. Clin Genet. 1974;5(3):242–247. doi: 10.1111/j.1399-0004.1974.tb01689.x. [DOI] [PubMed] [Google Scholar]
  587. Saffer D., Morley J., Bill P. L. Carbohydrate metabolism in motor neurone disease. J Neurol Neurosurg Psychiatry. 1977 Jun;40(6):533–537. doi: 10.1136/jnnp.40.6.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  588. Salvaggio J. E., Flax M. H., Leskowitz S. Studies in immunization. 3. The use of beryllium as a granuloma-producing agent in Freund's adjuvant. J Immunol. 1965 Nov;95(5):846–854. [PubMed] [Google Scholar]
  589. Samezima K., Nakamura K., Orii H. The role of ferritin in the in vivo localization of Gallium-67. Int J Nucl Med Biol. 1981;8(1):94–95. doi: 10.1016/0047-0740(81)90058-9. [DOI] [PubMed] [Google Scholar]
  590. Sampson M., Clarkson D., Davies D. D. DNA Synthesis in Aluminum-Treated Roots of Barley. Science. 1965 Jun 11;148(3676):1476–1477. doi: 10.1126/science.148.3676.1476. [DOI] [PubMed] [Google Scholar]
  591. Sanderson C., McLachlan D. R., De Boni U. Inhibition of corticosterone binding in vitro, in rabbit hippocampus, by chromatin bound aluminum. Acta Neuropathol. 1982;57(4):249–254. doi: 10.1007/BF00692179. [DOI] [PubMed] [Google Scholar]
  592. Sandstead H. H. Trace elements in uremia and hemodialysis. Am J Clin Nutr. 1980 Jul;33(7):1501–1508. doi: 10.1093/ajcn/33.7.1501. [DOI] [PubMed] [Google Scholar]
  593. Sargent T., 3rd, Stauffer H. Whole-body counting of retention of 67Cu, 32P and 51Cr in man. Int J Nucl Med Biol. 1979;6(1):17–21. doi: 10.1016/0047-0740(79)90062-7. [DOI] [PubMed] [Google Scholar]
  594. Sartwell P. E., Edwards L. B. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974 Apr;99(4):250–257. doi: 10.1093/oxfordjournals.aje.a121609. [DOI] [PubMed] [Google Scholar]
  595. Sayato Y., Nakamuro K., Matsui S., Ando M. Metabolic fate of chromium compounds. I. Comparative behavior of chromium in rat administered with Na251CrO4 and 51CrCl3. J Pharmacobiodyn. 1980 Jan;3(1):17–23. doi: 10.1248/bpb1978.3.17. [DOI] [PubMed] [Google Scholar]
  596. Scheffel U., Tsan M. F. Effect of serum unbound iron-binding capacity on the tissue distribution of 67Ga in abscess-bearing rabbits. Nuklearmedizin. 1980 Dec;19(6):274–277. [PubMed] [Google Scholar]
  597. Scheiber S. C., Ziesat H., Jr Dementia dialytica: a new psychotic organic brain syndrome. Compr Psychiatry. 1976 Nov-Dec;17(6):781–785. doi: 10.1016/0010-440x(76)90028-6. [DOI] [PubMed] [Google Scholar]
  598. Schneck M. K., Reisberg B., Ferris S. H. An overview of current concepts of Alzheimer's disease. Am J Psychiatry. 1982 Feb;139(2):165–173. doi: 10.1176/ajp.139.2.165. [DOI] [PubMed] [Google Scholar]
  599. Schoen R. T., Trentham D. E. Drug-induced lupus: an adjuvant disease? Am J Med. 1981 Jul;71(1):5–8. doi: 10.1016/0002-9343(81)90250-3. [DOI] [PubMed] [Google Scholar]
  600. Schofield J. D., Weightman B. New knowledge of connective tissue ageing. J Clin Pathol Suppl (R Coll Pathol) 1978;12:174–190. [PMC free article] [PubMed] [Google Scholar]
  601. Schramel P., Wolf A., Klose B. J. Direktbestimmung von Aluminium in Serumprobel mittels Inductively Coupled Plasma (ICP)-Emissionsspektralanalyse. J Clin Chem Clin Biochem. 1980 Sep;18(9):591–593. [PubMed] [Google Scholar]
  602. Schreeder M. T. Dialysis encephalopathy. Arch Intern Med. 1979 May;139(5):510–511. [PubMed] [Google Scholar]
  603. Schreeder M. T., Favero M. S., Hughes J. R., Petersen N. J., Bennett P. H., Maynard J. E. Dialysis encephalopathy and aluminum exposure: an epidemiologic analysis. J Chronic Dis. 1983;36(8):581–593. doi: 10.1016/0021-9681(83)90146-7. [DOI] [PubMed] [Google Scholar]
  604. Schroeder H. A., Balassa J. J. Abnormal trace metals in man: zirconium. J Chronic Dis. 1966 May;19(5):573–586. doi: 10.1016/0021-9681(66)90095-6. [DOI] [PubMed] [Google Scholar]
  605. Schroeder H. A., Mitchener M., Balassa J. J., Kanisawa M., Nason A. P. Zirconium, niobium, antimony and fluorine in mice: effects on growth, survival and tissue levels. J Nutr. 1968 May;95(1):95–101. doi: 10.1093/jn/95.1.95. [DOI] [PubMed] [Google Scholar]
  606. Schroeder H. A., Mitchener M. Life-term studies in rats: effects of aluminum, barium, beryllium, and tungsten. J Nutr. 1975 Apr;105(4):421–427. doi: 10.1093/jn/105.4.421. [DOI] [PubMed] [Google Scholar]
  607. Schroeder H. A., Mitchener M. Scandium, chromium(VI), gallium, yttrium, rhodium, palladium, indium in mice: effects on growth and life span. J Nutr. 1971 Oct;101(10):1431–1437. doi: 10.1093/jn/101.10.1431. [DOI] [PubMed] [Google Scholar]
  608. Schwartz J., Elizan T. S. Search for viral particles and virus-specific products in idiopathic Parkinson disease brain material. Ann Neurol. 1979 Sep;6(3):261–263. doi: 10.1002/ana.410060314. [DOI] [PubMed] [Google Scholar]
  609. Seger R., Buchinger G., Ströder J. On the influence of age on immunity in Down's syndrome. Eur J Pediatr. 1977 Jan 26;124(2):77–87. doi: 10.1007/BF00477543. [DOI] [PubMed] [Google Scholar]
  610. Seidel A., Vladár M., Volf V. Der Einfluss der isotopischen Verdünnung auf das Verhalten von Radioyttrium im Säugetierorganismus. Strahlentherapie. 1970 Dec;140(6):717–720. [PubMed] [Google Scholar]
  611. Selkoe D. J., Ihara Y., Salazar F. J. Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science. 1982 Mar 5;215(4537):1243–1245. doi: 10.1126/science.6120571. [DOI] [PubMed] [Google Scholar]
  612. Selkoe D. J., Liem R. K., Yen S. H., Shelanski M. L. Biochemical and immunological characterization of neurofilaments in experimental neurofibrillary degeneration induced by aluminum. Brain Res. 1979 Mar 16;163(2):235–252. doi: 10.1016/0006-8993(79)90352-4. [DOI] [PubMed] [Google Scholar]
  613. Sephton R. G., Harris A. W. Gallium-67 citrate uptake by cultured tumor cells, stimulated by serum transferrin. J Natl Cancer Inst. 1975 May;54(5):1263–1266. doi: 10.1093/jnci/54.5.1263. [DOI] [PubMed] [Google Scholar]
  614. Sephton R. G., Harris A. W. Studies on the uptake of 67 Ga and 59 Fe and the binding of transferrin by cultured mouse tumour cells. Int J Nucl Med Biol. 1981;8(4):333–339. doi: 10.1016/0047-0740(81)90040-1. [DOI] [PubMed] [Google Scholar]
  615. Sephton R. G., Kraft N. 67Ga and 59Fe uptakes by cultured human lymphoblasts and lymphocytes. Cancer Res. 1978 May;38(5):1213–1216. [PubMed] [Google Scholar]
  616. Sephton R. Relationships between the metabolism of 67 Ga and iron. Int J Nucl Med Biol. 1981;8(4):323–331. doi: 10.1016/0047-0740(81)90039-5. [DOI] [PubMed] [Google Scholar]
  617. Serpersu E. H., Kirch U., Schoner W. Demonstration of a stable occluded form of Ca2+ by the use of the chromium complex of ATP in the Ca2+-ATPase of sarcoplasmic reticulum. Eur J Biochem. 1982 Feb;122(2):347–354. doi: 10.1111/j.1432-1033.1982.tb05887.x. [DOI] [PubMed] [Google Scholar]
  618. Seto B. G. Mechanism of systemic allergy: report of a case involving an aluminum chloride solution. J Oral Med. 1982 Jul-Sep;37(3):87–94. [PubMed] [Google Scholar]
  619. Shenker B. J., Matarazzo W. J., Hirsch R. L., Gray I. Trace metal modification of immunocompetence. I. Effect of trace metals in the cultures on in vitro transformation of B lymphocytes. Cell Immunol. 1977 Nov;34(1):19–24. doi: 10.1016/0008-8749(77)90225-8. [DOI] [PubMed] [Google Scholar]
  620. Sherman L., Glennon J. A., Brech W. J., Klomberg G. H., Gordon E. S. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism. 1968 May;17(5):439–442. doi: 10.1016/0026-0495(68)90066-8. [DOI] [PubMed] [Google Scholar]
  621. Shore D., Millson M., Holtz J. L., King S. W., Bridge T. P., Wyatt R. J. Serum aluminum in primary degenerative dementia. Biol Psychiatry. 1980 Dec;15(6):971–977. [PubMed] [Google Scholar]
  622. Shore D., Wyatt R. J. Aluminum and Alzheimer's disease. J Nerv Ment Dis. 1983 Sep;171(9):553–558. doi: 10.1097/00005053-198309000-00005. [DOI] [PubMed] [Google Scholar]
  623. Short A. I., Winney R. J., Robson J. S. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. Proc Eur Dial Transplant Assoc. 1980;17:226–233. [PubMed] [Google Scholar]
  624. Shpakova A. P., Ermakova N. G. Izuchenie osobennostei funktsional'nogo sostoianiia limfotsitov krovi u bol'nykh berilliozom metodom blast-transformatsii. Sov Med. 1979 Apr;(4):20–24. [PubMed] [Google Scholar]
  625. Sideman S., Manor D. The dialysis dementia syndrome and aluminum intoxication. Nephron. 1982;31(1):1–10. doi: 10.1159/000182595. [DOI] [PubMed] [Google Scholar]
  626. Siegel N., Coughlin R., Haug A. A thermodynamic and electron paramagnetic resonance study of structural changes in calmodulin induced by aluminum binding. Biochem Biophys Res Commun. 1983 Sep 15;115(2):512–517. doi: 10.1016/s0006-291x(83)80174-0. [DOI] [PubMed] [Google Scholar]
  627. Siegel N., Haug A. Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim Biophys Acta. 1983 Apr 14;744(1):36–45. doi: 10.1016/0167-4838(83)90337-0. [DOI] [PubMed] [Google Scholar]
  628. Simon M., Alexandre J. L., Fauchet R., Genetet B., Bourel M. The genetics of hemochromatosis. Prog Med Genet. 1980;4:135–168. [PubMed] [Google Scholar]
  629. Sirover M. A., Loeb L. A. Infidelity of DNA synthesis in vitro: screening for potential metal mutagens or carcinogens. Science. 1976 Dec 24;194(4272):1434–1436. doi: 10.1126/science.1006310. [DOI] [PubMed] [Google Scholar]
  630. Sirover M. A., Loeb L. A. Metal-induced infidelity during DNA synthesis. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2331–2335. doi: 10.1073/pnas.73.7.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  631. Sissoëff I., Grisvard J., Guillé E. Studies on metal ions-DNA interactions: specific behaviour of reiterative DNA sequences. Prog Biophys Mol Biol. 1976;31(2):165–199. doi: 10.1016/0079-6107(78)90008-1. [DOI] [PubMed] [Google Scholar]
  632. Sjögren B., Lundberg I., Lidums V. Aluminium in the blood and urine of industrially exposed workers. Br J Ind Med. 1983 Aug;40(3):301–304. doi: 10.1136/oem.40.3.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  633. Skilleter D. N., Price R. J. Apparent two phase beryllium labelling of hepatic cell nuclei isolated after intravenous administration of beryllium compounds to rats. A possible explanation. Arch Toxicol. 1980 May;45(1):75–80. doi: 10.1007/BF00303298. [DOI] [PubMed] [Google Scholar]
  634. Skilleter D. N., Price R. J. The role of lysosomes in the hepatic accumulation and release of beryllium. Biochem Pharmacol. 1979 Dec 15;28(24):3595–3599. doi: 10.1016/0006-2952(79)90405-2. [DOI] [PubMed] [Google Scholar]
  635. Skilleter D. N., Price R. J. The uptake and subsequent loss of beryllium by rat liver parenchymal and non-parenchymal cells after the intravenous administration of particulate and soluble forms. Chem Biol Interact. 1978 Mar;20(3):383–396. doi: 10.1016/0009-2797(78)90116-3. [DOI] [PubMed] [Google Scholar]
  636. Sklan D., Dubrov D., Eisner U., Hurwitz S. 51Cr-EDTA, 91Y and 141Ce as nonabsorbed reference substances in the gastrointestinal tract of the chicken. J Nutr. 1975 Dec;105(12):1549–1552. doi: 10.1093/jn/105.12.1549. [DOI] [PubMed] [Google Scholar]
  637. Slater D. N., Underwood J. C., Durrant T. E., Gray T., Hopper I. P. Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Br J Dermatol. 1982 Jul;107(1):103–108. doi: 10.1111/j.1365-2133.1982.tb00297.x. [DOI] [PubMed] [Google Scholar]
  638. Smith D. M., Jr, Pitcock J. A., Murphy W. M. Aluminum-containing dense deposits of the glomerular basement membrane: identification by energy dispersive X-ray analysis. Am J Clin Pathol. 1982 Mar;77(3):341–346. doi: 10.1093/ajcp/77.3.341. [DOI] [PubMed] [Google Scholar]
  639. Smith D., DeFronzo R. A. Insulin resistance in uremia mediated by postbinding defects. Kidney Int. 1982 Jul;22(1):54–62. doi: 10.1038/ki.1982.132. [DOI] [PubMed] [Google Scholar]
  640. Sobue G., Matsuoka Y., Mukai E., Takayanagi T., Sobue I., Hashizume Y. Spinal and cranial motor nerve roots in amyotrophic lateral sclerosis and X-linked recessive bulbospinal muscular atrophy: morphometric and teased-fiber study. Acta Neuropathol. 1981;55(3):227–235. doi: 10.1007/BF00691322. [DOI] [PubMed] [Google Scholar]
  641. Sobue G., Matsuoka Y., Mukai E., Takayanagi T., Sobue I. Pathology of myelinated fibers in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis. J Neurol Sci. 1981 Jun;50(3):413–421. doi: 10.1016/0022-510x(81)90153-2. [DOI] [PubMed] [Google Scholar]
  642. Solheim L. P., Fromm H. J. A simple method for removing aluminum from adenosine-5'-triphosphate. Anal Biochem. 1980 Dec;109(2):266–269. doi: 10.1016/0003-2697(80)90647-8. [DOI] [PubMed] [Google Scholar]
  643. Solomon F. Binding sites for calcium on tubulin. Biochemistry. 1977 Feb 8;16(3):358–363. doi: 10.1021/bi00622a003. [DOI] [PubMed] [Google Scholar]
  644. Sorenson J. R., Campbell I. R., Tepper L. B., Lingg R. D. Aluminum in the environment and human health. Environ Health Perspect. 1974 Aug;8:3–95. doi: 10.1289/ehp.7483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  645. Speed R. M. The effects of ageing on the meiotic chromosomes of male and female mice. Chromosoma. 1977 Nov 30;64(3):241–254. doi: 10.1007/BF00328080. [DOI] [PubMed] [Google Scholar]
  646. Spencer H., Lender M. Adverse effects of aluminum-containing antacids on mineral metabolism. Gastroenterology. 1979 Mar;76(3):603–606. [PubMed] [Google Scholar]
  647. Spencer H., Lender M. Adverse effects of aluminum-containing antacids on mineral metabolism. Gastroenterology. 1979 Mar;76(3):603–606. [PubMed] [Google Scholar]
  648. Spina C. A., Smith D., Korn E., Fahey J. L., Grossman H. J. Altered cellular immune functions in patients with Down's syndrome. Am J Dis Child. 1981 Mar;135(3):251–255. doi: 10.1001/archpedi.1981.02130270043015. [DOI] [PubMed] [Google Scholar]
  649. Sprince N. L., Kazemi H., Hardy H. L. Current (1975) problem of differentiating between beryllium disease and sarcoidosis. Ann N Y Acad Sci. 1976;278:654–664. doi: 10.1111/j.1749-6632.1976.tb47079.x. [DOI] [PubMed] [Google Scholar]
  650. Stanhope J. M., Brody J. A., Morris C. E. Epidemiologic features of amyotropic lateral sclerosis and parkinsonism-dementia in Guam, Mariana Islands. Int J Epidemiol. 1972 Autumn;1(3):199–210. doi: 10.1093/ije/1.3.199. [DOI] [PubMed] [Google Scholar]
  651. Steinhagen W. H., Cavender F. L., Cockrell B. Y. Six month inhalation exposures of rats and guinea pigs to aluminum chlorhydrate. J Environ Pathol Toxicol. 1978 Jan-Feb;1(3):267–277. [PubMed] [Google Scholar]
  652. Sternweis P. C., Gilman A. G. Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc Natl Acad Sci U S A. 1982 Aug;79(16):4888–4891. doi: 10.1073/pnas.79.16.4888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  653. Stickland L. H. The activation of phosphoglucomutase by metal ions. Biochem J. 1949;44(2):190–197. doi: 10.1042/bj0440190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  654. Stiel J. N. The incidence of gastrectomy and gastric secretion in motor neuron disease. Australas Ann Med. 1967 May;16(2):176–177. doi: 10.1111/imj.1967.16.2.176. [DOI] [PubMed] [Google Scholar]
  655. Stoffyn M. Biological control of dissolved aluminum in seawater: experimental evidence. Science. 1979 Feb 16;203(4381):651–653. doi: 10.1126/science.203.4381.651. [DOI] [PubMed] [Google Scholar]
  656. Stone C. J., McLaurin D. A., Steinhagen W. H., Cavender F. L., Haseman J. K. Tissue deposition patterns after chronic inhalation exposures of rats and guinea pigs to aluminum chlorhydrate. Toxicol Appl Pharmacol. 1979 Jun 15;49(1):71–76. doi: 10.1016/0041-008x(79)90278-3. [DOI] [PubMed] [Google Scholar]
  657. Strohmeyer G., Gottesbüren H., Behr C., Sauer H. Diabetes mellitus bei idiopathischer Hämochromatose. Dtsch Med Wochenschr. 1976 Jul 9;101(28):1055–1060. doi: 10.1055/s-0028-1104213. [DOI] [PubMed] [Google Scholar]
  658. Sugawara S., Mikamo K. An experimental approach to the analysis of mechanisms of meiotic nondisjunction and anaphase lagging in primary oocytes. Cytogenet Cell Genet. 1980;28(4):251–264. doi: 10.1159/000131538. [DOI] [PubMed] [Google Scholar]
  659. Sviridov N. K. Aliuminii v patologii cheloveka. (Obzor literatury) Lab Delo. 1966;12:699–702. [PubMed] [Google Scholar]
  660. Swartzendruber D. C., Nelson B., Hayes R. L. Gallium-67 localization in lysosomal-like granules of leukemic and nonleukemic murine tissues. J Natl Cancer Inst. 1971 May;46(5):941–952. [PubMed] [Google Scholar]
  661. TERRY R. D., PENA C. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS. J Neuropathol Exp Neurol. 1965 Apr;24:200–210. doi: 10.1097/00005072-196504000-00003. [DOI] [PubMed] [Google Scholar]
  662. TIPTON I. H., COOK M. J. Trace elements in human tissue. II. Adult subjects from the United States. Health Phys. 1963 Feb;9:103–145. doi: 10.1097/00004032-196302000-00002. [DOI] [PubMed] [Google Scholar]
  663. TIPTON I. H., SHAFER J. J. STATISTICAL ANALYSIS OF LUNG TRACE ELEMENT LEVELS. Arch Environ Health. 1964 Jan;8:58–67. doi: 10.1080/00039896.1964.10663632. [DOI] [PubMed] [Google Scholar]
  664. Tamaren J., Spuhler K., Sujansky E. Risk of Down syndrome among second- and third-degree relatives of a proband with trisomy 21. Am J Med Genet. 1983 Jul;15(3):393–403. doi: 10.1002/ajmg.1320150305. [DOI] [PubMed] [Google Scholar]
  665. Tandon S. K., Behari J. R., Kachru D. N. Distribution of chromium in poisoned rats. Toxicology. 1979 May;13(1):29–34. [PubMed] [Google Scholar]
  666. Tas S., Tam C. F., Walford R. L. Disulfide bonds and the structure of the chromatin complex in relation to aging. Mech Ageing Dev. 1980 Jan;12(1):65–80. doi: 10.1016/0047-6374(80)90030-5. [DOI] [PubMed] [Google Scholar]
  667. Terry R. D., Davies P. Dementia of the Alzheimer type. Annu Rev Neurosci. 1980;3:77–95. doi: 10.1146/annurev.ne.03.030180.000453. [DOI] [PubMed] [Google Scholar]
  668. Terry R. D., Peck A., DeTeresa R., Schechter R., Horoupian D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol. 1981 Aug;10(2):184–192. doi: 10.1002/ana.410100209. [DOI] [PubMed] [Google Scholar]
  669. Thomas M., Aldridge W. N. The inhibition of enzymes by beryllium. Biochem J. 1966 Jan;98(1):94–99. doi: 10.1042/bj0980094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  670. Thyberg J., Moskalewski S., Friberg U. Effects of colchicine and vinblastine on the phytohaemagglutinin-induced transformation of lymphocytes. J Cell Sci. 1977;27:183–198. doi: 10.1242/jcs.27.1.183. [DOI] [PubMed] [Google Scholar]
  671. Tkeshelashvili L. K., Shearman C. W., Zakour R. A., Koplitz R. M., Loeb L. A. Effects of arsenic, selenium, and chromium on the fidelity of DNA synthesis. Cancer Res. 1980 Jul;40(7):2455–2460. [PubMed] [Google Scholar]
  672. Tobin R. E., Schneider P. B. Uptake of 67Ga in the lactating breast and its persistence in milk: case report. J Nucl Med. 1976 Dec;17(12):1055–1056. [PubMed] [Google Scholar]
  673. Toda G., Hashimoto T., Asakura T., Minakami S. The inhibition of (Na+-K+)-activated ATPase by beryllium. Biochim Biophys Acta. 1967 Jul 3;135(3):570–572. doi: 10.1016/0005-2736(67)90049-1. [DOI] [PubMed] [Google Scholar]
  674. Tomimatsu Y., Donovan J. W. Spectroscopic evidence for perturbation of tryptophan in Al(III) and Ga(III) binding to ovotransferrin and human serum transferrin. FEBS Lett. 1976 Dec 1;71(2):299–302. doi: 10.1016/0014-5793(76)80955-6. [DOI] [PubMed] [Google Scholar]
  675. Tomlinson B. E., Kitchener D. Granulovacuolar degeneration of hippocampal pyramidal cells. J Pathol. 1972 Mar;106(3):165–185. doi: 10.1002/path.1711060305. [DOI] [PubMed] [Google Scholar]
  676. Tomlinson B. E. Plaques, tangles and Alzheimer's disease. Psychol Med. 1982 Aug;12(3):449–459. doi: 10.1017/s0033291700055549. [DOI] [PubMed] [Google Scholar]
  677. Trapp G. A., Miner G. D., Zimmerman R. L., Mastri A. R., Heston L. L. Aluminum levels in brain in Alzheimer's disease. Biol Psychiatry. 1978 Dec;13(6):709–718. [PubMed] [Google Scholar]
  678. Trapp G. A. Plasma aluminum is bound to transferrin. Life Sci. 1983 Jul 25;33(4):311–316. doi: 10.1016/s0024-3205(83)80002-2. [DOI] [PubMed] [Google Scholar]
  679. Traub R. D., Rains T. C., Garruto R. M., Gajdusek D. C., Gibbs C. J., Jr Brain destruction alone does not elevate brain aluminum. Neurology. 1981 Aug;31(8):986–990. doi: 10.1212/wnl.31.8.986. [DOI] [PubMed] [Google Scholar]
  680. Troncoso J. C., Price D. L., Griffin J. W., Parhad I. M. Neurofibrillary axonal pathology in aluminum intoxication. Ann Neurol. 1982 Sep;12(3):278–283. doi: 10.1002/ana.410120312. [DOI] [PubMed] [Google Scholar]
  681. Tsan M. F., Chen W. Y., Scheffel U., Wagner H. N., Jr Studies on gallium accumulation in inflammatory lesions: I. Gallium uptake by human polymorphonuclear leukocytes. J Nucl Med. 1978 Jan;19(1):36–43. [PubMed] [Google Scholar]
  682. Tsapakos M. J., Wetterhahn K. E. The interaction of chromium with nucleic acids. Chem Biol Interact. 1983 Sep 1;46(2):265–277. doi: 10.1016/0009-2797(83)90034-0. [DOI] [PubMed] [Google Scholar]
  683. Tsukagoshi H., Yanagisawa N., Oguchi K., Nagashima K., Murakami T. Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis. J Neurol Sci. 1979 May;41(3):287–297. doi: 10.1016/0022-510x(79)90089-3. [DOI] [PubMed] [Google Scholar]
  684. Turk J. L., Parker D. Granuloma formation in normal guinea pigs injected intradermally with aluminum and zirconium compounds. J Invest Dermatol. 1977 Jun;68(6):336–340. doi: 10.1111/1523-1747.ep12496358. [DOI] [PubMed] [Google Scholar]
  685. Turk J. L., Parker D. Sensitization with Cr, Ni and Zr salts and allergic type granuloma formation in the guinea pig. J Invest Dermatol. 1977 Jun;68(6):341–345. doi: 10.1111/1523-1747.ep12496465. [DOI] [PubMed] [Google Scholar]
  686. Tyndall R. L., Chaskes S. J., Carlton J. E., Nelson B., Daniel J. C. Gallium-67 distribution in pregnant mammals. J Exp Zool. 1976 Mar;195(3):417–423. doi: 10.1002/jez.1401950308. [DOI] [PubMed] [Google Scholar]
  687. UNDERWOOD A. L., NEUMAN W. F., ROUSER G. L. Studies on renal excretion of beryllium. Proc Soc Exp Biol Med. 1952 Jan;79(1):97–99. doi: 10.3181/00379727-79-19285. [DOI] [PubMed] [Google Scholar]
  688. Uchida T., Narabayashi K., Takeda S., Matsuzawa T. A study on accumulation mechanism of 111In in malignant tumor. Nihon Igaku Hoshasen Gakkai Zasshi. 1976 Dec 25;36(12):1107–1112. [PubMed] [Google Scholar]
  689. Uemura E., Hartmann H. A. Quantitative studies of neuronal RNA on the subiculum of demented old individuals. Brain Res Bull. 1979 May-Jun;4(3):301–305. doi: 10.1016/s0361-9230(79)80005-2. [DOI] [PubMed] [Google Scholar]
  690. Uemura E., Hartmann H. A. RNA content and volume of nerve cell bodies in human brain. I. Prefrontal cortex in aging normal and demented patients. J Neuropathol Exp Neurol. 1978 Sep;37(5):487–496. doi: 10.1097/00005072-197809000-00004. [DOI] [PubMed] [Google Scholar]
  691. Ulrich J. Senile plaques and neurofibrillary tangles of the Alzheimer type in nondemented individuals at presenile age. Gerontology. 1982;28(2):86–90. doi: 10.1159/000212515. [DOI] [PubMed] [Google Scholar]
  692. Unanue E. R., Askonas B. A., Allison A. C. A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol. 1969 Jul;103(1):71–78. [PubMed] [Google Scholar]
  693. Usher M. S., Westerman B. R., Ammerman E. G., Sutherland I. Long-term effects of indium administration in rats. J Nucl Med. 1970 Apr;11(4):155–157. [PubMed] [Google Scholar]
  694. Uusitupa M. I., Kumpulainen J. T., Voutilainen E., Hersio K., Sarlund H., Pyörälä K. P., Koivistoinen P. E., Lehto J. T. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr. 1983 Sep;38(3):404–410. doi: 10.1093/ajcn/38.3.404. [DOI] [PubMed] [Google Scholar]
  695. VISEK W. J., WHITNEY I. B., KUHN U. S., 3rd, COMAR C. L. Metabolism of Cr51 by animals as influenced by chemical state. Proc Soc Exp Biol Med. 1953 Dec;84(3):610–615. doi: 10.3181/00379727-84-20729. [DOI] [PubMed] [Google Scholar]
  696. Vacher J., Deraedt R., Benzoni J. Compared effects of two beryllium salts (soluble and insoluble): toxicity and blockade of the reticuloendothelial system. Toxicol Appl Pharmacol. 1973 Mar;24(3):497–506. doi: 10.1016/0041-008x(73)90056-2. [DOI] [PubMed] [Google Scholar]
  697. Vacher J. Immunological responses of guinea-pigs to beryllium salts. J Med Microbiol. 1972 Feb;5(1):91–108. doi: 10.1099/00222615-5-1-91. [DOI] [PubMed] [Google Scholar]
  698. Vacher J., Stoner H. B. The removal of injected beryllium from the blood of the rat. The role of the reticulo-endothelial system. Br J Exp Pathol. 1968 Aug;49(4):315–323. [PMC free article] [PubMed] [Google Scholar]
  699. Vacher J., Stoner H. B. The transport of beryllium in rat blood. Biochem Pharmacol. 1968 Jan;17(1):93–107. doi: 10.1016/0006-2952(68)90162-7. [DOI] [PubMed] [Google Scholar]
  700. Valberg L. S., Flanagan P. R., Haist J., Frei J. V., Chamberlain M. J. Gastrointestinal metabolism of gallium and indium: effect of iron deficiency. Clin Invest Med. 1981;4(2):103–108. [PubMed] [Google Scholar]
  701. Valentin H., Preusser P., Schaller K. H. Die Analyse von Aluminium im Serum und Urin zur Uberwachung exponierter Personen. Int Arch Occup Environ Health. 1976 Oct 21;38(1):1–17. doi: 10.1007/BF00378316. [DOI] [PubMed] [Google Scholar]
  702. Vallabhajosula S. R., Harwig J. F., Siemsen J. K., Wolf W. Radiogallium localization in tumors: blood binding and transport and the role of transferrin. J Nucl Med. 1980 Jul;21(7):650–656. [PubMed] [Google Scholar]
  703. Vaughan L. A., Weber C. W., Kemberling S. R. Longitudinal changes in the mineral content of human milk. Am J Clin Nutr. 1979 Nov;32(11):2301–2306. doi: 10.1093/ajcn/32.11.2301. [DOI] [PubMed] [Google Scholar]
  704. Veillon C., Wolf W. R., Guthrie B. E. Determination of chromium in biological materials by stable isotope dilution. Anal Chem. 1979 Jun;51(7):1022–1024. doi: 10.1021/ac50043a056. [DOI] [PubMed] [Google Scholar]
  705. Verbueken A. H., Van de Vyver F. L., Van Grieken R. E., Paulus G. J., Visser W. J., D'Haese P., De Broe M. E. Ultrastructural localization of aluminum in patients with dialysis-associated osteomalacia. Clin Chem. 1984 May;30(5):763–768. [PubMed] [Google Scholar]
  706. Versieck J., Cornelis R. Measuring aluminum levels. N Engl J Med. 1980 Feb 21;302(8):468–469. doi: 10.1056/NEJM198002213020818. [DOI] [PubMed] [Google Scholar]
  707. Versieck J., Hoste J., Barbier F., Steyaert H., De Rudder J., Michels H. Determination of chromium and cobalt in human serum by neutron activation analysis. Clin Chem. 1978 Feb;24(2):303–308. [PubMed] [Google Scholar]
  708. Vierstra R., Haug A. The effect of A13+ on the physical properties of membrane lipids in Thermoplasma acidophilum. Biochem Biophys Res Commun. 1978 Sep 14;84(1):138–143. doi: 10.1016/0006-291x(78)90274-7. [DOI] [PubMed] [Google Scholar]
  709. Viola M. V., Frazier M., White L., Brody J., Spiegelman S. RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients. J Exp Med. 1975 Aug 1;142(2):483–494. doi: 10.1084/jem.142.2.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  710. Viola R. E., Morrison J. F., Cleland W. W. Interaction of metal(III)-adenosine 5'-triphosphate complexes with yeast hexokinase. Biochemistry. 1980 Jul 8;19(14):3131–3137. doi: 10.1021/bi00555a003. [DOI] [PubMed] [Google Scholar]
  711. WATSON M. L., ALDRIDGE W. G. SELECTIVE ELECTRON STAINING OF NUCLEIC ACIDS. J Histochem Cytochem. 1964 Feb;12:96–103. doi: 10.1177/12.2.96. [DOI] [PubMed] [Google Scholar]
  712. WOODARD J. S. Clinicopathologic significance of granulovacuolar degeneration in Alzheimer's disease. J Neuropathol Exp Neurol. 1962 Jan;21:85–91. doi: 10.1097/00005072-196201000-00007. [DOI] [PubMed] [Google Scholar]
  713. Waldron-Edward D., Chan P., Skoryna S. C. Increased prothrombin time and metabolic changes with high serum aluminum levels following long-term exposure to Bayer-process alumina. Can Med Assoc J. 1971 Dec 18;105(12):1297–passim. [PMC free article] [PubMed] [Google Scholar]
  714. Walker G. S., Aaron J. E., Peacock M., Robinson P. J., Davison A. M. Dialysate aluminium concentration and renal bone disease. Kidney Int. 1982 Feb;21(2):411–415. doi: 10.1038/ki.1982.37. [DOI] [PubMed] [Google Scholar]
  715. Walker L. M., Sandler R. M. Acute myeloid leukaemia with monosomy-7 follows acute lymphoblastic leukaemia. Br J Haematol. 1978 Mar;38(3):359–366. doi: 10.1111/j.1365-2141.1978.tb01055.x. [DOI] [PubMed] [Google Scholar]
  716. Wang J. L., Gunther G. R., Edelman G. M. Inhibition by colchicine of the mitogenic stimulation of lymphocytes prior to the S phase. J Cell Biol. 1975 Jul;66(1):128–144. doi: 10.1083/jcb.66.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  717. Ward B. E., Cook R. H., Robinson A., Austin J. H. Increased aneuploidy in Alzheimer disease. Am J Med Genet. 1979;3(2):137–144. doi: 10.1002/ajmg.1320030204. [DOI] [PubMed] [Google Scholar]
  718. Ward M. K., Feest T. G., Ellis H. A., Parkinson I. S., Kerr D. N. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. Lancet. 1978 Apr 22;1(8069):841–845. doi: 10.1016/s0140-6736(78)90191-5. [DOI] [PubMed] [Google Scholar]
  719. Wardi A. H., Allen W. S., Varma R. Spectrophotometric determination of glycosaminoglycans as their scandium complexes with xylenol orange. Anal Chem. 1974 Jun;46(7):919–920. doi: 10.1021/ac60343a029. [DOI] [PubMed] [Google Scholar]
  720. Wardi A. H., Michos G. A. Spectrophotometric determination of acid mucopolysaccharides. Anal Biochem. 1973 Jan;51(1):274–279. doi: 10.1016/0003-2697(73)90475-2. [DOI] [PubMed] [Google Scholar]
  721. Warrell R. P., Jr, Coonley C. J., Straus D. J., Young C. W. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion. Cancer. 1983 Jun 1;51(11):1982–1987. doi: 10.1002/1097-0142(19830601)51:11<1982::aid-cncr2820511104>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  722. Warren G., Schultz P., Bancroft D., Bennett K., Abbott E. H., Rogers S. Mutagenicity of a series of hexacoordinate chromium (III) compounds. Mutat Res. 1981 Oct;90(2):111–118. doi: 10.1016/0165-1218(81)90073-2. [DOI] [PubMed] [Google Scholar]
  723. Watson E. E., Cloutier R. J., Gibbs W. D. Whole-body retention of 67Ga-citrate. J Nucl Med. 1973 Nov;14(11):840–842. [PubMed] [Google Scholar]
  724. Watts H., Kennedy P. G., Thomas M. The significance of anti-neuronal antibodies in Alzheimer's disease. J Neuroimmunol. 1981 Mar;1(1):107–116. doi: 10.1016/0165-5728(81)90013-8. [DOI] [PubMed] [Google Scholar]
  725. Wedelin C., Björkholm M., Holm G., Ogenstad S., Mellstedt H. Blood T-lymphocyte functions in healthy adults in relation to age. Scand J Haematol. 1982 Jan;28(1):45–53. doi: 10.1111/j.1600-0609.1982.tb02119.x. [DOI] [PubMed] [Google Scholar]
  726. Weick J. K., Stephens R. L., Baker L. H., Jones S. E. Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study. Cancer Treat Rep. 1983 Sep;67(9):823–825. [PubMed] [Google Scholar]
  727. Weiner R. E., Schreiber G. J., Hoffer P. B. In vitro transfer of Ga-67 from transferrin to ferritin. J Nucl Med. 1983 Jul;24(7):608–614. [PubMed] [Google Scholar]
  728. Weiner R. E., Schreiber G. J., Hoffer P. B., Shannon T. The relative stabilities of 67 Ga complexes of lactoferrin and transferrin at various pH's. Int J Nucl Med Biol. 1981;8(4):371–378. doi: 10.1016/0047-0740(81)90045-0. [DOI] [PubMed] [Google Scholar]
  729. Weiner R., Hoffer P. B., Thakur M. L. Lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes. J Nucl Med. 1981 Jan;22(1):32–37. [PubMed] [Google Scholar]
  730. Weinreb R. N., Yavitz E. Q., O'Connor G. R., Barth R. A. Lacrimal gland uptake of gallium citrate Ga 67. Am J Ophthalmol. 1981 Jul;92(1):16–20. doi: 10.1016/s0002-9394(14)75901-x. [DOI] [PubMed] [Google Scholar]
  731. Weisenberg R. C. Microtubule formation in vitro in solutions containing low calcium concentrations. Science. 1972 Sep 22;177(4054):1104–1105. doi: 10.1126/science.177.4054.1104. [DOI] [PubMed] [Google Scholar]
  732. Weitkamp L. R., Nee L., Keats B., Polinsky R. J., Guttormsen S. Alzheimer disease: evidence for susceptibility loci on chromosomes 6 and 14. Am J Hum Genet. 1983 May;35(3):443–453. [PMC free article] [PubMed] [Google Scholar]
  733. West K. M. Diabetes in American Indians and other native populations of the New World. Diabetes. 1974 Oct;23(10):841–855. doi: 10.2337/diab.23.10.841. [DOI] [PubMed] [Google Scholar]
  734. Whalley L. J., Carothers A. D., Collyer S., De Mey R., Frackiewicz A. A study of familial factors in Alzheimer's disease. Br J Psychiatry. 1982 Mar;140:249–256. doi: 10.1192/bjp.140.3.249. [DOI] [PubMed] [Google Scholar]
  735. White B. J., Crandall C., Goudsmit J., Morrow C. H., Alling D. W., Gajdusek D. C., Tijio J. H. Cytogenetic studies of familial and sporadic Alzheimer disease. Am J Med Genet. 1981;10(1):77–89. doi: 10.1002/ajmg.1320100110. [DOI] [PubMed] [Google Scholar]
  736. Wiesenhutter G. W., Sharma O. P. Is sarcoidosis an autoimmune disease?: Report of four cases and review of the literature. Semin Arthritis Rheum. 1979 Nov;9(2):124–144. doi: 10.1016/s0049-0172(79)80003-7. [DOI] [PubMed] [Google Scholar]
  737. Wilcox C. B., Caspary E. A., Behan P. O. Histocompatibility antigens in Alzheimer's disease. A preliminary study. Eur Neurol. 1980;19(4):262–265. doi: 10.1159/000115158. [DOI] [PubMed] [Google Scholar]
  738. Williams E. D., Elliott H. L., Boddy K., Haywood J. K., Henderson I. S., Harvey I., Kennedy A. C. Whole body aluminium in chronic renal failure and dialysis encephalopathy. Clin Nephrol. 1980 Oct;14(4):198–200. [PubMed] [Google Scholar]
  739. Williams W. J. Beryllium disease--pathology and diagnosis. J Soc Occup Med. 1977 Jul;27(3):93–96. [PubMed] [Google Scholar]
  740. Williams W. J. Granulomas in sarcoidosis and chronic beryllium disease. Verh Dtsch Ges Pathol. 1980;64:177–180. [PubMed] [Google Scholar]
  741. Williams W. R., Williams W. J. Development of beryllium lymphocyte transformation tests in chronic beryllium disease. Int Arch Allergy Appl Immunol. 1982;67(2):175–180. doi: 10.1159/000233010. [DOI] [PubMed] [Google Scholar]
  742. Wisniewski H. M., Soifer D. Neurofibrillary pathology: current status and research perspectives. Mech Ageing Dev. 1979 Jan;9(1-2):119–142. doi: 10.1016/0047-6374(79)90125-8. [DOI] [PubMed] [Google Scholar]
  743. Wisniewski H. M., Sturman J. A., Shek J. W. Aluminum chloride induced neurofibrillary changes in the developing rabbit a chronic animal model. Ann Neurol. 1980 Nov;8(5):479–490. doi: 10.1002/ana.410080505. [DOI] [PubMed] [Google Scholar]
  744. Wisniewski H. M., Sturman J. A., Shek J. W. Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum. Neurobiol Aging. 1982 Spring;3(1):11–22. doi: 10.1016/0197-4580(82)90056-2. [DOI] [PubMed] [Google Scholar]
  745. Wisniewski K., Cobill J. M., Wilcox C. B., Caspary E. A., Williams D. G., Wisniewski H. M. T lymphocytes in patients with Down's syndrome. Biol Psychiatry. 1979 Jun;14(3):463–471. [PubMed] [Google Scholar]
  746. Wisniewski K., Jervis G. A., Moretz R. C., Wisniewski H. M. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol. 1979 Mar;5(3):288–294. doi: 10.1002/ana.410050311. [DOI] [PubMed] [Google Scholar]
  747. Witschi H. P., Aldridge W. N. Uptake, distribution and binding of beryllium to organelles of the rat liver cell. Biochem J. 1968 Feb;106(4):811–820. doi: 10.1042/bj1060811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  748. Witschi H. P., Alldridge W. N. Biochemical changes in rat liver after acute beryllium poisoning. Biochem Pharmacol. 1967 Feb;16(2):263–278. doi: 10.1016/0006-2952(67)90028-7. [DOI] [PubMed] [Google Scholar]
  749. Witschi H. P. Effects of beryllium on deoxyribonucleic acid-synthesizing enzymes in regenerating rat liver. Biochem J. 1970 Dec;120(3):623–634. doi: 10.1042/bj1200623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  750. Witschi H. Inhibition of deoxyribonucleic acid synthesis in regenerating rat liver by beryllium. Lab Invest. 1968 Jul;19(1):67–70. [PubMed] [Google Scholar]
  751. Wiśniewski H. M., Ghetti B., Terry R. D. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol. 1973 Oct;32(4):566–584. doi: 10.1097/00005072-197310000-00007. [DOI] [PubMed] [Google Scholar]
  752. Wiśniewski H., Narkiewicz O., Wiśniewska K. Topography and dynamics of neurofibrillar degeneration in aluminum encephalopathy. Acta Neuropathol. 1967 Oct 20;9(2):127–133. doi: 10.1007/BF00691437. [DOI] [PubMed] [Google Scholar]
  753. Wiśniewski H., Terry R. D. Experimental colchicine encephalopathy. I. Induction of neurofibrillary degeneration. Lab Invest. 1967 Dec;17(6):577–587. [PubMed] [Google Scholar]
  754. Wiśniewski H., Terry R. D., Hirano A. Neurofibrillary pathology. J Neuropathol Exp Neurol. 1970 Apr;29(2):163–176. [PubMed] [Google Scholar]
  755. Womack F. C., Colowick S. P. Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5080–5084. doi: 10.1073/pnas.76.10.5080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  756. Wong P. C., Lai J. C., Lim L., Davison A. N. Selective inhibition of L-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminium, manganese, and cadmium chloride. J Inorg Biochem. 1981 Jun;14(3):253–260. doi: 10.1016/s0162-0134(00)80005-7. [DOI] [PubMed] [Google Scholar]
  757. Woolliscroft J., Barbosa J. Analysis of chromium induced carbohydrate intolerance in the rat. J Nutr. 1977 Sep;107(9):1702–1706. doi: 10.1093/jn/107.9.1702. [DOI] [PubMed] [Google Scholar]
  758. YEN S. S. ABNORMAL CARBOHYDRATE METABOLISM AND PREGNANCY. A STUDY AMONG PREGNANT GUAMANIAN WOMEN. Am J Obstet Gynecol. 1964 Oct 15;90:468–473. doi: 10.1016/0002-9378(64)90803-8. [DOI] [PubMed] [Google Scholar]
  759. Yagihashi S., Kaseda N. Age-related changes of glomerular basement membrane in normal rats. Tohoku J Exp Med. 1978 Sep;126(1):27–49. doi: 10.1620/tjem.126.27. [DOI] [PubMed] [Google Scholar]
  760. Yamamoto A., Wada O., Ono T. A low-molecular-weight, chromium-binding substance in mammals. Toxicol Appl Pharmacol. 1981 Jul;59(3):515–523. doi: 10.1016/0041-008x(81)90305-7. [DOI] [PubMed] [Google Scholar]
  761. Yanagihara R. T., Garruto R. M., Gajdusek D. C. Epidemiological surveillance of amyotrophic lateral sclerosis and parkinsonism-dementia in the Commonwealth of the Northern Mariana Islands. Ann Neurol. 1983 Jan;13(1):79–86. doi: 10.1002/ana.410130117. [DOI] [PubMed] [Google Scholar]
  762. Yanagihara R. Heavy metals and essential minerals in motor neuron disease. Adv Neurol. 1982;36:233–247. [PubMed] [Google Scholar]
  763. Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet. 1972 Aug 12;2(7772):292–296. doi: 10.1016/s0140-6736(72)92903-0. [DOI] [PubMed] [Google Scholar]
  764. Yasui M., Yoshimasu F., Yase Y., Uebayashi Y. Wilson's disease; increased aluminum in liver. Folia Psychiatr Neurol Jpn. 1979;33(4):547–552. doi: 10.1111/j.1440-1819.1979.tb03194.x. [DOI] [PubMed] [Google Scholar]
  765. Yeh S. D., Kim W. S. Gallium uptake in heterotransplanted human choriocarcinoma and ovarian carcinoma in nude mice. Proc Soc Exp Biol Med. 1980 Nov;165(2):361–363. doi: 10.3181/00379727-165-40986. [DOI] [PubMed] [Google Scholar]
  766. Yen S. H., Gaskin F., Terry R. D. Immunocytochemical studies of neurofibrillary tangles. Am J Pathol. 1981 Jul;104(1):77–89. [PMC free article] [PubMed] [Google Scholar]
  767. Yokel R. A. Toxicity of aluminum exposure during lactation to the maternal and suckling rabbit. Toxicol Appl Pharmacol. 1984 Aug;75(1):35–43. doi: 10.1016/0041-008x(84)90073-5. [DOI] [PubMed] [Google Scholar]
  768. Yoshida S. [X-ray microanalysis of amyotrophic lateral sclerosis. (1) Metal distribution compared with neuropathological findings in the cervical spinal cord]. Rinsho Shinkeigaku. 1977 May;17(5):299–309. [PubMed] [Google Scholar]
  769. Yoshimasu F., Uebayashi Y., Yase Y., Iwata S., Sasajima K. Studies on amyotrophic lateral sclerosis by neutron activation analysis. Folia Psychiatr Neurol Jpn. 1976;30(1):49–55. doi: 10.1111/j.1440-1819.1976.tb00110.x. [DOI] [PubMed] [Google Scholar]
  770. Yoshimasu F., Yasui M., Yase Y., Iwata S., Gajdusek D. C., Gibbs C. J., Jr, Chen K. M. Studies on amyotrophic lateral sclerosis by neutron activation analysis--2. Comparative study of analytical results on Guam PD, Japanese ALS and Alzheimer disease cases. Folia Psychiatr Neurol Jpn. 1980;34(1):75–82. doi: 10.1111/j.1440-1819.1980.tb01515.x. [DOI] [PubMed] [Google Scholar]
  771. ZINSSER H. H., BUTT E. M., LEONARD J. Metal content correlation in aging aorta. J Am Geriatr Soc. 1957 Jan;5(1):20–26. doi: 10.1111/j.1532-5415.1957.tb00024.x. [DOI] [PubMed] [Google Scholar]
  772. Zarfas D. E., Wolf L. C. Maternal age patterns and the incidence of Down's syndrome. Am J Ment Defic. 1979 Jan;83(4):353–359. [PubMed] [Google Scholar]
  773. Zimmet P., Taft P., Guinea A., Guthrie W., Thoma K. The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia. 1977 Apr;13(2):111–115. doi: 10.1007/BF00745137. [DOI] [PubMed] [Google Scholar]
  774. Zumkley H., Bertram H. P., Lison A., Knoll O., Losse H. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency. Clin Nephrol. 1979 Jul;12(1):18–21. [PubMed] [Google Scholar]
  775. Zuppinger K., Engel E., Forbes A. P., Mantooth L., Claffey J. Klinefelter's syndrome, a clinical and cytogenetic study in twenty-four cases. Acta Endocrinol (Copenh) 1967;54(Suppl):5+–5+. doi: 10.1530/acta.0.054s005. [DOI] [PubMed] [Google Scholar]
  776. Zuppinger K., Molinari B., Hirt A., Imbach P., Gugler E., Tönz O., Zurbrügg R. P. Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload. Helv Paediatr Acta. 1979;34(3):197–207. [PubMed] [Google Scholar]
  777. den HARTOG JAGER W. A., BETHLEM J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry. 1960 Nov;23:283–290. doi: 10.1136/jnnp.23.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  778. den Jager W. A. Histochemistry of adrenal bodies in Parkinson's disease. Arch Neurol. 1970 Dec;23(6):528–533. doi: 10.1001/archneur.1970.00480300050006. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES